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ABSTRACT
Jasin, Lisa, R. DNP. Miami Valley-College of Nursing and Health, Wright State
University, 2014. Alcohol, Tobacco and Illicit Drug Screening in Pregnancy.

Intrauterine substance exposure is a nationally growing problem. A steady increase in
neonates with neonatal abstinence syndrome in the state of Ohio was noted.
Prenatal substance use presents a significant burden to society. Of infants exposed to
intrauterine opiates, 55-94 percent develop signs of withdrawal. For example, the
estimated lifetime cost for a neonate with fetal alcohol spectrum disorder is $2 million.
The purpose of this evidence based practice improvement project was to evaluate the
utility of the 5Ps screening tool and brief intervention by community health workers
during the first prenatal home visit. The Evidence-Based Practice Improvement (EBPI)
model guided the project. The prenatal screening tools previously used by community
health workers focused on only one substance and asked primarily direct questions.
Evidence supports asking a combination of direct and indirect questions for improving
recognition of risk. Screening followed by a brief intervention suggests improvement in
patient outcomes. Community health workers caring for prenatal women were educated
about the use of the 5Ps tool, motivational interviewing and practice of a brief
intervention. Sixteen staff members were surveyed before and after the education. Staff
outcome measures were ease of use, comfort with, and intention to use the 5Ps tool.
Patient outcomes included use of the 5Ps, identification of risk, and documentation of
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discussion or intervention. A significant difference was noted between total average
score on the pretest (M=27.12, SD=11.29) and total average score on the posttest
(M=14.81, SD=9.99) p< .001. Particularly, there was a significant difference in staff
member’s knowledge of the 5Ps tool (p< .031). Retrospective chart review before and
after staff education revealed a significant difference in the use of the 5Ps, p< .022.
Individually, there was a significant difference in documentation of a substance
intervention or discussion p< .030. Further study with a larger sample size is needed to
determine the effect of the 5Ps tool on the prenatal population served by community
health workers. Staff involved in treating pregnant women benefited from education in
motivational interviewing and use of a brief intervention.
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I. INTRODUCTION
Problem Statement
Intrauterine substance exposure, which includes tobacco, alcohol and illicit drugs,
is a growing problem nationally, including the state of Ohio, which demonstrates a steady
increase in neonates requiring treatment for neonatal abstinence syndrome (Walsh et al.,
2012). Intrauterine exposure to illicit drugs, tobacco and alcohol are associated with
neonatal comorbidities such as intrauterine growth restriction, prematurity and low birth
weight (Bada et al., 2005; Cornelius, Goldschmidt, Day, & Larkby, 2002; Ostrea et al.,
2001). Comorbidities which arise from maternal substance use, regardless of the
substance used, place an undue burden on the healthcare system and society as a whole
(Hudak & Tan, 2012). The maternal substances used during pregnancy and related
comorbidities are broad with varying neonatal manifestations.
Intrauterine exposure to marijuana may be associated with long term
neurodevelopmental effects (Campolongo, Trezza, Palmary, Trabace, & Cuomo, 2009),
as well as reduced height at 6 years of age (Cornelius, et. al, 2002). Whereas, intrauterine
exposure to opiates may result in neonatal abstinence syndrome (NAS) requiring
pharmacologic treatment and prolonged hospital stay (Hudak & Tan, 2012), as well as
risk for mild developmental impairment (Bunikowski et al., 1998; Schuler, Nair, &
Kettinger, 2003). Intrauterine exposure to cocaine and other stimulants may result in
NAS like behavior that may last up to seven days, but may reflect the effects of the drug
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as opposed to withdrawal from the drug (Hudak & Tan, 2012). Intrauterine exposure to
alcohol is associated with fetal alcohol spectrum disorder (FASD), preterm birth,
miscarriage, stillbirth and short stature (Centers for Disease Control and Prevention
[CDC], 2013; Cornelius et al., 2002; March of Dimes, 2012). Intrauterine exposure to
tobacco from 1995-1999 resulted in over 1000 infant deaths each year from prematurity
related causes including respiratory distress syndrome, low birth weight, and increased
risk of sudden infant death syndrome (CDC, 2002).
Background and Significance
Considering the myriad consequences of intrauterine substance exposure, in the
absence of prematurity or other congenital defects, newborns facing withdrawal from
intrauterine opiate exposure require the most immediate treatment. Of infants exposed to
intrauterine opiates, 55-94 percent of neonates will develop signs of withdrawal (Hudak
& Tan, 2012). From 2009 to 2011 there was an increase from 200 to more than 300
neonates treated for neonatal abstinence syndrome (intrauterine exposure to opiates) at
four of the Ohio Children’s Hospitals (Walsh et al., 2012). Treatment of neonatal
abstinence syndrome is variable with length of treatment in the Ohio Children’s Hospitals
from 14.4 to 41.8 days (Walsh et al., 2012). This resulted in a range of cost per patient of
approximately $18,922 to $54,925 for each hospital stay (R. McClead, personal
communication, September 1, 2013).
Neonatal abstinence syndrome is a constellation of symptoms in a neonate
exposed to opiates in utero. When the umbilical cord is cut and the neonate’s source of
opiate is removed, withdrawal may result. Other substances may also cause symptoms
similar to NAS, prolong the severity of symptoms or increase the time needed to treat
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NAS. These substances include tobacco, cocaine, barbiturates, alcohol and hypnoticssedatives (Hudak & Tan, 2012). Symptoms of NAS may require pharmacologic
treatment and prolonged hospital stay beyond the typical 48 to 72 hour stay. NAS
primarily affects the gastrointestinal and neurologic systems and may lead to difficulties
in the neonate’s ability to sleep, eat, maintain temperature and gain weight. The most
severe consequences of NAS, though rare, are seizure activity and/or death (Hudak &
Tan, 2012).
In the six freestanding Ohio Children’s Hospitals from January 2012 to July 2013,
547 neonates requiring pharmacologic treatment for NAS were studied by the Ohio
Children’s Hospital Association Neonatal Abstinence Working Group to determine the
demographics of pregnant women using substances whose newborns required
pharmacologic treatment for NAS. This study also collected data on the treatment plans
for the newborns born to these women, and the lengths of stay associated with the
treatment used to treat withdrawal in these infants (Walsh et al., 2012). Maternal
demographics of the women studied included mothers who were primarily Caucasian and
using public insurance. White, non-Hispanic women accounted for 91.5 percent of
mothers in the study, and 79.5 percent of mothers used public insurance. Of the neonates
studied, 81.5 percent were exposed to tobacco, 9.7 percent were exposed to alcohol, and
58 percent were exposed to any illicit substance. Any illicit substance included illicit
drugs including marijuana, cocaine, methamphetamines, opiates obtained and used
illegally, or abuse of prescription opiates. The most common opiates used were
buprenorphine, oxycodone, heroin and methadone, which may have been used with a
prescription or misused without a prescription (Walsh et al., 2012).
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A proxy measure to identify the significance of potential intrauterine exposure to
substances can be measured by the rate of unintentional death from drug overdose. The
rate of unintentional death from drug overdose increased in Ohio from 3.6 per 100,000
deaths in 2000 to 16.59 per 100,000 in 2012 (Ohio Department of Health [ODH], 2014).
The demographics for unintentional fatal overdose rate by sex include 43 percent females
compared to 57 percent males, with females at highest risk for prescription opioid deaths
(ODH, 2014). While the proportion of unintentional overdose in males decreased from
70 percent to 61 percent from 2000 through 2011, the unintentional overdose rate in
females increased from 30 percent to 38 percent during those same years (ODH, 2013).
The unintentional overdose death rate is used as a proxy measure for maternal drug use as
there is not a good measure of general drug use in pregnancy (M. Walsh, personal
communication, September 11, 2013).
A computerized anonymous survey is performed by SAMHSA annually to
determine overall and maternal substance use in the United States. Nationwide, among
pregnant women between the ages of 15 to 44, an average of 5.9 percent used illicit
drugs, 8.5 percent reported alcohol usage, 15.9 percent reported cigarette use in the
previous month, 2.7 percent reported binge drinking and 0.3 percent reported heavy
drinking based on data obtained for 2011-2012 (Substance Abuse and Mental Health
Services Administration [SAMHSA], 2013). Cigarette use in non-pregnant women has
declined since 2003, but cigarette use in pregnant women has not declined significantly
(SAMHSA, 2013). There is no universal screening of pregnant women for substance
use. Most data is self-reported and estimated to be grossly underreported (M. Walsh,
personal communication, September 11, 2013).
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Maternal substance use and the sequelae associated with use present a significant
burden to society. The national hospital charge to treat NAS in 2009 was $53,400 with
an average length of stay of 16 days. This resulted in a daily cost of $3,337.50 (Patrick et
al., 2012). In 2009, state Medicaid programs were responsible for 77.6 percent of
charges for NAS treatment (Patrick et al., 2012). This is consistent with the Ohio
Children’s Hospital findings in 2012-2013. In Columbus, Ohio the average allowed cost
per day for Medicaid Managed care patients in 2012-2013 was $1,314 (R. McClead,
personal communication, September 1, 2013). At an average length of stay of 20.5 days,
this results in a cost of $26,937 per neonate treated for NAS in Ohio compared to the
average Medicaid cost of $8,600 for a vaginal delivery without complications (Merrill &
Steiner, 2006). The cost for fetal alcohol spectrum disorder is calculated as a lifetime
cost by the Centers for Disease Control with a lifetime estimate of $2 million (CDC,
2012). The most recent data reported by CDC stated an average cost of $704 per
maternal smoker in 1996 which accounted for 2.6 percent of total neonatal medical
expenditures for 1996 (CDC, 2002). These data are old; however, no further current data
has been reported.
Healthy People 2020 objectives, while not quality objectives, do offer guidance
for quality initiatives to improve abstinence from alcohol, tobacco and illicit drugs during
pregnancy. Healthy People 2020 guidelines are listed in the Maternal, Infant and Child
Health (MICH) section. MICH section 11 targets increased abstinence from alcohol,
tobacco and illicit drugs among pregnant women. The goal for MICH 11.1 is that 98.3
percent of pregnant women age 15 to 44 will report abstinence from alcohol for the past
30 days, which would result in a ten percent improvement from a baseline of 89.4 percent
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reported in 2007-2008. MICH 11.2 targets 100 percent of pregnant women abstain from
binge drinking in the past 30 days, a target with improvement from the reported baseline
of 95 percent in 2007-2008. Objective MICH 11.3 targets 98.6 percent of pregnant
women will report abstinence from tobacco use while pregnant, resulting in a ten percent
improvement from the reported 89.6 percent baseline in 2007. MICH objective 11.4
targets 100% of pregnant women from age 15 to 44 will abstain from illicit drugs in the
past 30 days, a target with improvement from the baseline of 94.8 percent in 2007-2008.
(United States Department of Health and Human Services [USDHHS], 2013).
Prevention of NAS, FASD, and other sequelae of intrauterine substance exposure
can only be accomplished with intervention prior to conception or during the antenatal
period of pregnancy. Therefore, the focus of prevention needs to be directed toward the
mother. Prenatal screening along with a brief intervention shows promise in the detection
of pregnant women at risk for alcohol, tobacco and illicit drug use during pregnancy as
well as those who are continuing to use substances (Chasnoff et al., 2005; Kennedy,
Finkelstein, Hutchins, & Mahoney, 2004; Wong, Ordean, & Kahan, 2011; Wyble, 2013).
Interaction with health care providers has been determined to be the number one
incentive for women toward changing patterns of substance use during pregnancy (Office
of Disease Prevention and Health Promotion [ODPHP], 2009). A single interaction with
a health care provider who addresses the risk of substance use can make a difference in a
woman’s use of substances while pregnant (ODPHP, 2009). There is a need to
understand what screening tools are available to determine risk for and/or use of
substances during pregnancy, as well as the types of brief intervention that have been
proven to be effective to decrease maternal substance use in pregnancy. Through use of
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the evidence-based practice (EBP) process, available maternal substance use screening
tools were explored, including those tools that included a brief intervention.
Purpose
The purpose of this evidence based practice improvement project was to evaluate
the use of a standardized screening tool and brief intervention by community health
workers during intake interviews during the first prenatal home visit.
Formulate Focused Clinical Question
PICOT question. A clinical question was developed to enable the DNP student
to conduct a directed literature search to obtain a body of evidence available regarding
the clinical problem. The PICOT format is an acronym that identifies factors to assist in
identification of the appropriate evidence, which is the most relevant evidence to answer
the clinical question. The “P” stands for patient population or disease, “I” stands for
intervention or issue of interest, “C” stands for the comparison intervention or issue of
interest, “O” stands for outcome of interest, and “T” stands for time frame for evaluation
of an outcome (Melnyk & Fineout-Overholt, 2011).
The following PICOT question was developed prior the literature review: “In
pregnant women, how does a standardized screening tool compared to free form
substance use questions affect disclosure of substance use within the first prenatal home
intake visit?”
Guiding Framework
The guiding framework chosen for this project was the Evidence-Based Practice
Improvement (EBPI) model (Levin et al., 2010). Levin’s EBPI model merges
components of the evidence based practice process with steps of quality improvement for
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implementation. The model consists of seven steps to guide the development and
implementation of the evidence based practice improvement project. The steps of the
EBPI model are shown in Figure 1.
The systematic approach of Levin’s EBPI model (Figure 1; Permissions to reprint
Appendix A and B) provides clear direction to an evidence based practice change. The
model also provides a systematic guide to implementation of the practice change that
results in measurement of outcome through the PDSA cycle or small tests of change
(Levin et al., 2010). The EBPI model begins with the description of the problem. The
problem in this evidence based practice project is intrauterine exposure to substance
during a woman’s pregnancy. This led to the second step and formulation of a focused
clinical question, the PICOT question. The PICOT question informed and enabled the
third step, which is the directed literature search.
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Figure 1. The steps of the EBPI model by R. F. Levin, J. M. Keefer, J.
Marren, M. Vetter, B. Lauder and A. Sobolewski, 2010. Evidence-Based
Practice Improvement: Merging 2 Paradigms. Journal of Nursing Care
Quarterly, 25, P. 122. Reprinted with permission
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II. EVIDENCE
Search for Evidence
The literature search was conducted using the PubMed, CINAHL, and Cochrane
databases. In addition, hand searching was performed from applicable references found
in the “keeper articles” bibliographic section. Key words used included “drug use”,
“illicit drug use”, “substance use”, “alcohol”, “tobacco”, “smoking”, “screening”,
“screening tools”, “substance abuse detection”, “pregnancy”, “prenatal care”, “perinatal”,
“expectant mothers”, and “SBIRT”. No publication date limit was placed on the search,
as some prenatal substance screening tools were developed in the 1980’s and remain in
use. Articles were included if they addressed a substance use screening tool used in a
prenatal population or developed for a prenatal population.
A PubMed search using the phrase and Boolean connectors “drug use AND
screening tools AND prenatal” garnered 38 articles, of which six were appropriate to the
topic. Phrases in PubMed included “substance use AND screening tools”, “pregnancy
AND drug use screening tools”, “Illicit drug use AND pregnancy screening” resulted in
the abstraction of ten additional articles. Further phrases and Boolean terms used in
PubMed were “perinatal AND drug use AND screening”, “illicit drug use AND
pregnancy screening”, “pregnancy AND drug use screening tools”, “drug use AND
screening tools AND prenatal”, “substance use AND screening tools” revealed 31
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articles, resulting in twelve articles not previously found. The phrase “substance use
screening tool” led to 118 articles, of which five were appropriate.
A CINAHL search using the phrases and Boolean connectors “expectant mothers
AND screening AND drug use”, “perinatal substance use AND screening”, and “prenatal
substance use AND screening” returned 13 articles, three of which had not been
previously obtained in the PubMed search. A search of the Cochrane Database using the
phrase and Boolean connector “substance use screening AND pregnan*”, and “illicit drug
use and prenatal” resulted in 16 results, 13 of which, were trials and one of which was the
protocol for an upcoming trial. The final result was two randomized trials and one
relevant Cochrane review. A total of 17 articles were abstracted and critically appraised
to make the recommendation for change.
Appraisal and Synthesis of the Evidence
Screening tools
There are multiple screening tools available for use to screen for alcohol, tobacco
and substance use. Not all were created for use with pregnant women (Screening
Instruments for Pregnant Women, 2012). The Substance Use Risk Profile-Pregnancy
Scale was developed for use with pregnant women. The scale has potential to predict
women at high risk for alcohol or illicit substances, but does not screen for tobacco use or
family violence (Yonkers et al., 2010).
The TWEAK and T-ACE screening tools were developed from alcohol abuse
screening tools, and were designed to minimize guilt-associated questions in relation to
alcohol use in pregnancy. The TWEAK and T-ACE screening tools were both based on
the CAGE and Michigan Alcohol Screening tool and adapted to address alcohol use in
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pregnancy (Sarker, Einarson, & Koren, 2010). The revised CAGE alcohol was revised
for alcohol use and identifies heavy alcohol use, while the modified CAGE drug tool
identifies heavy drug use (Midanik, Zahnd, & Klein, 1998). Neither the revised CAGE
alcohol nor the modified CAGE drug tool is useful for identification of risk or light use
(Midanik, Zahnd, & Klein, 1998).
The 4P’s Plus was developed by Ira Chasnoff based on Hope Ewing’s 4P’s
screening tool (The Institute for Health and Recovery [IHR], n.d.) for use with pregnant
women who may or may not be at risk for substance use. The 4P’s Plus was designed to
be used with the general population, as opposed to only the identified at risk population,
to avoid the pitfalls of targeted screening (Chasnoff et al., 2005). Chasnoff and
colleagues (2005) found that the most highly educated and most affluent women had the
highest rate of substance use. The 4P’s Plus uses four questions regarding parents,
partner, past and pregnancy related use of alcohol or drugs. The 4P’s Plus also asks how
many cigarettes were smoked in the month prior to learning of pregnancy. The 4P’s Plus
identifies pregnant women at risk for substance use, but does not address family violence
(Chasnoff et al., 2005). The 4P’s Plus identifies those women with light or infrequent
alcohol use, as well as heavier alcohol users. The 4P’s Plus demonstrates high
sensitivity, with good specificity and has a high negative predictive value, as well as low
positive predictive validity (Chasnoff, Wells, McGourty, & Bailey, 2007).
The Drug Use Disorder (DUD) Questionnaire focuses on alcohol and drug use,
and was not tested on pregnant women. When it was validated, the validation group was
noted to be low risk. The DUD Questionnaire does not screen for tobacco use or physical
violence (Scherer, Furr-Holden, & Voas, 2013). The CRAFFT questionnaire was
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embedded in a general screening tool and found to be a useful tool in identifying risk for
alcohol or drug use in pregnant women. The CRAFFT did not screen for tobacco use.
The majority of women in the survey were older than 25 years (Braaten, Briegleb, Hauke,
Niamkey, & Chang, 2008).
The Institute of Healthcare and Recovery’s 5P’s was developed based on Ewing’s
4P’s, but with the questions reversed to address parent’s, partner’s and peer’s alcohol and
drug use prior to asking the pregnant woman about individual alcohol or drug use. This
involves both indirect and direct questioning and proceeds from non-threatening to more
threatening questioning. In addition, the 5P’s includes questions concerning tobacco use
and family violence. Any positive response garners a brief intervention. While there was
a risk of over-identifying women at risk for alcohol or drug use, it is one of the few
screening tools that screens for any alcohol use (Kennedy, Finkelstein, Hutchins, &
Mahoney, 2004). Table 1 reflects evaluation of the literature regarding maternal
substance use screening tools.
The prenatal screening tools in use primarily focus on drugs, alcohol, or tobacco,
and ask the pregnant mother directly about use. The evidence supports asking a
combination of direct and indirect questions to reveal a higher number of mothers at risk
for alcohol, tobacco and illicit drug use (Ondersma et al., 2012).
Previous cigarette smoking or alcohol use is significantly correlated with present
alcohol or drug use (Chasnoff, Neuman, Thornton, & Callaghan, 2001; Slutsker, Smith,
Higginson, & Fleming, 1993). Pre-pregnancy alcohol and cannabis use is correlated with
use of pre-pregnancy alcohol and cannabis use is correlated with use of alcohol or
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Table 1. Substance use screening tools
Citation

Design/
Method

Sample/
Setting

Major
Variables
Studied and
Their
Definitions

Outcome
Measurement

Data
Analysis

Findings

Level of
Evidence

Quality of
Evidence:
Critical
Worth to
Practice

(Kennedy et al., 2004)

Descriptive
study.
Staff trained
and
interviewed
after training
on ASAP tool
and after
training in
brief
intervention

118 prenatal staff
trained on ASAP
screening
175 prenatal staff
trained on Brief
Intervention

Education of
staff in use of
ASAP tool.
This is the
intervention

36% of
women
screened
were
positive for
at least one
risk factor
with 5P’s
screening.

Percentages
without
statistical
analysis

89% of
respondents
reported the tool
as an effective
method of
identifying
pregnant women
at risk for
alcohol/substance
abuse.
74% of
respondents
reported they
learned new info
about risks of
alcohol/drug use
by pregnant
women
95% of patients
screened at initial
prenatal visit.

VI

Strengths:
Tool was
easily
integrated
into
workflow as
evidenced by
95% use
rate.
Staff felt
tool would
be effective.

Improving Screening for
Alcohol Use During
Pregnancy: The
Massachusetts ASAP
Program

No information
as to attrition
between training
and completion
of post training
interview
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4439 of 4660
pregnant women
served at initial
appointment by
community
health centers
and private
practices (11
sites) were
screened (95%).
No exclusion
criteria, but those
women who
refused were
counted as not
screened.

Use of tool for
consistent
screening for
substance use.
This is an
outcome

(Reliability
and validity
training is in
process per
Enid
Watson).

77% received
brief intervention
if screened
positive for >1
risk factor
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Screening
for alcohol
use and /or
abuse as
well as brief
interventions
for alcohol
and
substance
use can be
effectively
delivered.
Limitations:
No statistical
analysis of
tool.

Citation

Design/
Method

Sample/
Setting

Major
Variables
Studied and
Their
Definitions

Outcome
Measurement

Data
Analysis

Findings

Level of
Evidence

Quality of
Evidence:
Critical Worth
to Practice

(Chasnoff et al., 2005)

Descriptive

5 sites in CA, NJ,
and Il used the 4
P’s Plus screening
tool at the first
prenatal intake
visit.
No exclusion
criteria existed.
90% of women
which totaled
7818 women
across 5 sites were
screened. No
explanation as to
attrition of 10% of
eligible women

Screening with
4P’s Plus
Screen for
substance use

Percentages
were used
to
determine
revelation
of
substance
use

Chi Square
test of
independence
for rates of
substance use
across four
sites

Significant
decrease in rates of
substance use after
knowledge of
pregnancy.
P<0.0001

VI

Strengths:
Verbal
screening=
higher rate
substance use
than clinically
guided urine
toxicology.
> than 90% of
women
screened.
Identified
small amounts
of alcohol use
as opposed to
larger amounts
of alcohol use.
Designed for
pregnant
women.
Limitations:
Validity &
reliability not
tested.
Very feasible
to implement

The 4P’s Plus Screen for
Substance Use in
Pregnancy: Clinical
Applications and
Outcomes

Revelation of
substance use
in pregnancy

26

Camden NJ site
performed only
screening, no
follow up.

26

Rates of substance
use across four
sites 352.7.
San Louis Obispo:
rate of substance
use 50% in
pregnancy
Southern
Illinois:37%
Chicago:20%
Ventura: 16%
P<0.001.
Clinical tests=1.2%
positive urine tox
in overall
population.
37%admitted to use
of alcohol/illicit
drugs to 4 P’s Plus

Citation

Design/
Method

Sample/
Setting

Major
Variables
Studied and
Their
Definitions

Outcome
Measurement

Data
Analysis

Findings

Level of
Evidence

Quality of
Evidence:
Critical
Worth to
Practice

(Chasnoff et al., 2007)

Validation/
Descriptive

All pregnant
women 18 years
and older
eligible.
228 women
initially screened
of 387 eligible.
No exclusion
criteria noted

No variables
manipulated

Not noted

Percentage

Internal
consistency 0.62
(low but
acceptable)

VI

Strengths:
Validity and
Reliability
data noted,
but measures
note noted.
May be
straight
percentages.

Validation of the 4P’s Plus
screen for substance use in
pregnancy validation of
the 4P’s Plus.

Sensitivity 0.871
Specificity 0.761
Positive predictive
value 0.364

27

Negative
predictive value
0.974

27

Limitations
Internal
consistency
low at 0.62.
Positive
predictive
value low,
but negative
predictive
value high.
Indicates
excess
clinical
assessment
performed

Citation

(Braaten,
Briegleb, Hauke,
Niamkey, &
Chang, 2008)
Screening
Pregnant Young
Adults for
Alcohol and Drug
Use: A Pilot
Study

Design/
Method

Sample/
Setting

Major
Variables
Studied and
Their
Definitions

Outcome
Measurement

Data
Analysis

Findings

Level of
Evidence

Quality of
Evidence:
Critical Worth
to Practice

100 patients
from Young
Adult
Reproductive
Medicine Clinic

CRAFFT
screen
questions
about alcohol
and drug use
(embedded in
health survey)

One answer of
yes is positive
finding

Descriptive
results as
percentages,
means with
standard
deviations,
and medians.

15 (18.75%) of women had
at least one positive score

VI

Addresses
alcohol and
drug use.

80 of 100 were
pregnant and
less than 25
years old (final
focus of study)

Chi square
or t-tests to
determine
differences
between two
groups of
women.

Most frequently positive
score was for “have you
ever ridden in a CAR with
someone (including
yourself) who was high or
had been using alcohol or
drugs?”
Trend toward lower
gestational age with higher
CRAFFT score.

28

Trend toward higher number
of positive women willing to
participate in further
research; older women more
willing to participate in
further research

28

Copyright by
Boston
Children’s
Hospital.
Embedded in
another survey.
Direct
questions
Does not
address tobacco

Citation

Design/
Method

Sample/
Setting

Major
Variables
Studied and
Their
Definitions

Outcome
Measurement

Data
Analysis

Findings

Level of
Evidence

Quality of
Evidence:
Critical Worth
to Practice

(Sarker et al.,
2010)

Descripti
ve cohort
study,
comparis
on of two
tools

202 candidates
recruited – these
were pregnant
women who
called the
helpline to selfreport use of
alcohol at least
2 months prior
to or during
pregnancy.
175 women
were enrolled,
75 problem
drinkers and
100 nonproblem
drinkers.

No variables
manipulated
Comparison of
effectiveness
of TWEAK
and T-ACE
tools at
identifying at
risk drinkers
who called the
Mother risk
helpline

Validation of
TWEAK using
cut points of
either 2 or 3,
which is
population
dependent,
however, the
population was
not defined.

SPSS:
Chi-square
analysis to
deter diff in
women
determined
to be
problem
drinkers vs
non-problem
drinkers

Higher number of single or
divorced women who
identified themselves as
problem drinkers.

VI

Weaknesses:
TWEAK false
positive 64%
T-ACE false
positive 81%

Assessment and
Detection:
Comparing the
Effectiveness of
TWEAK and TACE in
Determining
Problem Drinkers
in Pregnancy

29

No explanation
for women who
did not enroll.

T-ACE has
been validated
with a cut
point of 2 in
the population
on which it
was tested.
The population
was not
defined.

Student t-test
and/or
MannWhitney Utest used to
compare
sensitivity
and
specificity
rates
between
TWEAK and
T-ACE
tools.

29

TWEAK:
Capture at risk drinkers with
sensitivity of 99%
CP>/=2
Sensitivity 100%
Specificity 19%
PPV 0.48
CP>/=3
Sensitivity 93%
Specificity 34%
PPV 0.51
T-ACE
Cut point >/=2
Sensitivity 100%
Specificity 36%
PPV 0.54
Cut point >/=3
Sensitivity 99%
Specificity 43%
PPV 0.54

Conclusions:
TWEAK and
T-Ace are not
ideal alone to
identify
problem
drinkers in a
population of
pregnant
women seeking
help from a
helpline

Citation

Design/
Method

Sample/
Setting

Major
Variables
Studied and
Their
Definitions

Outcome
Measurement

Data
Analysis

Findings

Level of
Evidence

Quality of
Evidence:
Critical Worth
to Practice

(Yonkers et al.,
2010)

Epidemio
logical
survey

Convenience
sample of all
pregnant
women who
presented
between 2005
and 2009 for
obstetric care.
2,684 women
screened. >80%
African
American or
Hispanic. 73%
20-34 years old
No exclusion
criteria

No variable
manipulated

No reliability
scale noted

Model fit
characteristi
cs –
Akaike’s
Information
Criterion,
(AI)
Nagelkerke
R (NR)
Sensitivity
Specificity

SURP
Low risk pop
AI-579.74
NR-0.27
Sens-91%
Spec- 67%
High-risk pop.
AI-616.93
NR – 0.2
Sens-57%
Spec- 88%
TWEAK
AI – 610.69
NR-0.22
Sens-63%
Spec-86%
4P’s (2007)
AI-625.77
NR-0.19
Sens-82%
Spec-68%
4P’s (2005) (Mod=positive)
AI-647.25
NR-0.15
Sens-95%
Spec-45%
4P’s (2005) (mod=neg)
AI-625.10
NR-0.19
Sens-81%
Spec-69%

VI

Strengths:
Most predictive
of alcohol and
illicit drug use.
Identified
women at high
risk for cocaine,
sedative and
opiate use.

Screening for
Perinatal
Substance Use;
Development of
the Substance
Use Risk ProfilePregnancy Scale

30
30

Weakness:
Validation
group noted to
be low risk and
sensitivity and
specificity may
vary.
No indication
for tobacco risk
SURP
measures:
Alcohol
Marijuana
Cocaine
Sedatives
Opioids

Citation

Design/
Method

Sample/
Setting

Major Variables
Studied and
Their Definitions

Outcome
Measurement

Data
Analysis

Findings

Level of
Evidence

Quality of
Evidence:
Critical
Worth to
Practice

(Scherer, FurrHolden, & Voas,
2013)

Descriptive/
Survey
Blood and
oral fluid
toxicology

Subset of US
National
Road side
Survey.
Administered
to day and
night time
drivers in 48
states.
N=2,702
(stated
positive use
of at least one
of three
substances) of
10,909
drivers who
were eligible
to participate.

Questions
regarding
Substance abuse
(use in the last
year) and
substance
dependence

DUD
questionnaire
assessed
substance
abuse and
dependence
based on self
report

Logistic
regression
analysis

1,940 marijuana use
239 (12.3%) met
criteria for abuse 130
(6.7%) met criteria
for dependence
1,266 cocaine use
97 (7.6%) met
criteria for abuse, 59
(4.6%) met criteria
for dependence
2,017 reported
painkiller use
209 (10.3%) met
criteria for abuse, 98
(4.8%) met criteria
for dependence

VI

Not
developed
for, used
with or
validated in
pregnant
women

Drug Use Disorder
(DUD)
Questionnaire:
Scale Development
and validation

Toxicology for
oral fluid for use
of marijuana,
cocaine and
extramedicinal
painkillers

31

Blood toxicology
for use of
marijuana, cocaine
and
extramedicinal
pain killers

Screened with
enzyme linked
immuneabsorbent
assays with
verification
with liquid
chromatograph
y-mass
spectroscopy
(LC/MS)
Screened with
enzyme linked
immuneabsorbent
assays with
verification
with LC/MS

31

Chi square
Comparative
fit analysis
Nonnormed fit
index
Standardized
root mean
square error of
appropriation
Standardized
root mean
square error
residual

DUD showed
adequate fit for all
substances measured
Cronbach’s Alpha
Subscale of
substance abuse .71
to .84
Subscale of
dependence
.83 to .92

Did not
address risk
of substance
use
Did not
address use
of tobacco or
alcohol

cannabis use during pregnancy (Chang et al., 2011). A woman’s revelation of alcohol or
tobacco use in the month prior to pregnancy was a better predictor of substance use
during pregnancy than admission or denial during pregnancy (Chasnoff et al., 2005). A
combination of direct and indirect questioning showed more promise in detecting current
drug use than either indirect or direct questioning alone (Ondersma et al., 2012).
Marijuana use was revealed by interview more frequently than by chart review or
toxicology testing (O’Campo et al., 1992; Ostrea et al., 2001). Table 2 shows prepregnancy correlations with prenatal substance use.
Interview alone regarding substance use did not encourage behavior change
(Chang et al., 2011). Screening followed by a brief intervention involving at least one
visit showed improvement in outcomes (Goler, Armstrong, Taillac, & Osejo, 2008).
Recommendations have been made to screen all pregnant women for alcohol use (Clark,
Dawson, & Martin, 1999; Floyd et al., 2008) followed by a brief intervention (Floyd et
al., 2008). Further recommendations have been made to screen all pregnant women for
substance use, provide brief intervention as needed and provide referrals as needed
(American College of Obstetricians and Gynecologists [ACOG] Committee on Ethics,
2004; Floyd et al., 2008).
Staff involved in counseling pregnant women about behavior change would
benefit from education and training in motivational interviewing and brief intervention
(Chang et al., 2008). A Cochrane review discussed prenatal and postnatal home visits by
certified community health workers and noted seven studies with 803 mother infant pairs.
The home visits were primarily conducted after birth and thus are not compatible with the
design of this evidence based project. Findings from the review suggest that there was
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Table 2. Correlations with substance use
Citation

Design/
Method

Sample/
Setting

Major
Variables
Studied and
Their
Definitions

Outcome
Measurement

Data
Analysis

Findings

Level of
Evidence

Quality of Evidence:
Critical Worth to
Practice

(Chang et al.,
2011)

Cross-sectional
study
Survey
followed by
interview

30 pregnant
young adults
up to age 25

DSM-IV
substance
use disorder
module

Self-report of drug
and alcohol use as
well as the context
within which the
alcohol or drugs
would be used

Descriptive
statistics using
percentages,
means and
standard
deviations.

90% of women were
single

VI

Pre-pregnancy alcohol
and cannabis use was
associated with
prenatal alcohol and
cannabis use.

Self-Reported
Alcohol and Drug
Use in Pregnant
Young Women:
A Pilot Study of
Prevalence and
Associated
Factors

Drinking
within the
six months
prior to the
interview

Fisher’s exact
test to compare
demographics
Wilcoxon’s test

33

Drinking in
settings:
intimate,
socially, and
negative
coping

Logistic
regression to
measure the area
under the curve

Likelihood
of behavior
change

While pregnant:
8 (27%) drank
average of 1.8
drinks/day (4% of
days were drinking
days).
3 (10%) smoked an
average of 4.3
marijuana cigarettes
on days they smoked
(88% of days).
1 woman used both
alcohol and marijuana
7 women fit DSM-IV
criteria for lifetime
alcohol use disorders,
1 had a current
disorder.
9 met criteria for
lifetime cannabis use
disorder.

33

Small sample size
limits generalizability.
No women indicated
they would change
behavior based on the
interview alone,
leading the authors to
recommend brief
intervention or
counseling.

Citation

Design/
Method

Sample/
Setting

Major
Variables
Studied and
Their
Definitions

Outcome
Measurement

Data
Analysis

Findings

Level of
Evidence

Quality of Evidence:
Critical Worth to
Practice

Ondersma et al.,
2012

Descriptive

Four hundred
low income,
post-partum
primarily
(92%)
African
American
women.
Convenience
sample from
an obstetrical
unit –
inpatients.
300 women in
the
developmenta
l sample and
100 in the
crossvalidation
sample

Direct
questions
regarding
drug use

Drug use
consequences in
last year – 10 item.
Questions re
marijuana, other
drug use in past 3
months

Item reduction
based on 10-90%
endorsement
rates.

54.8% of women
testing positive for
drug use reported
drug use in 3 months
before pregnancy
In cross-validation,
10% of women
testing positive for
drug use reported
drug use in the 3
months before
pregnancy

VI

Applicable to low
income African
American Postpartum
women.
Screener not tested on
women who were
pregnant at the time of
survey

Development and
preliminary
validation of an
indirect screener
for drug use in
the perinatal
period

Survey on
computer
Toxicology
samples of hair
and urine

34

Recruitment
from Feb
2008 through
Sept 2009

Indirect
questions
regarding
associated
behaviors of
drug use
Semiindirect
questions
regarding
drug use
Urine for
toxicology
for illicit
drugs
Hair for
toxicology
for illicit
drugs

Smoking, pain,
mental health,
married, violence,
positive if cut point
3 or more
Drug use in the 3
months prior to
becoming pregnant
Cocaine,
marijuana, or
stimulants (short
window of
detection)
Marijuana, cocaine,
opiates,
methamphetamine,
MDMA, and PCP.
Lag of 5-7 days to
appearance in hair

34

Tetrachoric
correlation
coefficients to
retain top 30
items. Logistic
regression
resulted in 6
questions
remaining.
In crossvalidation
sample, t-test
was performed.

Area under the curve
showed 0.74 (fair)
with t-test with tvalue 51.6 and
p<0.0001
(significant)
compared to DAST10 (direct questions).
Combined
indirect/direct
approach: incr.
accuracy - 72% in
dev sample, 71% in
validation sample

Citation

Design/
Method

Sample/
Setting

Major
Variables
Studied and
Their
Definitions

Outcome
Measurement

Data
Analysis

Findings

Level of
Evidence

Quality of Evidence:
Critical Worth to
Practice

(Slutsker, Smith,
Higginson, &
Fleming, 1993)

Descriptive/
Survey of birth
attendants,
birth certificate
review

All women
who delivered
a singleton
infant
residing in
Oregon
during
November
1989

Survey
questions:
Selfreporting of
illicit drug
use

Marijuana, cocaine,
heroin,
methamphetamine
or others.

Fisher exact test,
chi-squared test.
Comparisons
were made with
t-tests.

5.2% (n-144) of 2791
women were
recognized as having
used illicit drugs.

VI

Attendants who
routinely asked about
drug use were twice as
likely to identify drug
use.

Recognizing
Illicit Drug Use
by Pregnant
Women: Reports
from Oregon
Birth Attendants

35

3200 women
gave birth.
2791 (87%)
of mothers
had surveys
of birth
attendants and
birth
certificate
data that
could be
linked and
were the final
sample.

Mother/baby
lab testing
for illicit
drugs during
pregnancy or
postpartum
period
Usual policy
regarding
asking about
drug use or
testing for
drug use

Laboratory tests
alone identified 13
of the 125 drug
users. Urine testing
was done on 40 of
the identified users.
Drug use was
recognized by 6%
of attendants who
routinely asked vs
3% in those who
did not ask about
drug use.
Tobacco, alcohol or
drug use reported.
Characteristics of
pregnancy.

Birth
certificate
data

35

Primarily
percentages used

OR = 2.1
CI = 1.2, 3.7

Univariate
analysis.
Illicit drug use
reduced birth
weight by
estimated 80g
(p=0.05)

125 drug users were
recognized by birth
attendant survey.
Birth certificates
identified 59 users
(40 of whom who
were also identified
by attendant survey)
Drug users were more
likely than non-users
to use alcohol (22%)
and tobacco (74%)
during the current
pregnancy, tobacco
use was most strongly
associated with drug
use.

Tobacco use most
highly correlates with
drug use. Alcohol
correlates with drug
use.
Decreased birth
weight is associated
with illicit drug use.

Citation

Design/
Method

Sample/
Setting

Major
Variables
Studied and
Their
Definitions

Outcome
Measurement

Data
Analysis

Findings

Level of
Evidence

Quality of Evidence:
Critical Worth to
Practice

(O’Campo et al.,
1992)

Descriptive/
Personal
interview
(prenatal
interviews X
3)
Medical record
review

Women
attending first
prenatal visit
at Johns
Hopkins
Hospital
Obstetrical
Clinic for
their first
prenatal visit.
Over 18 years
old.
672 women
recruited, 638
study
participants.

Recent illicit
drug use
defined as
drug use in
the last year
revealed in
interview.

Marijuana, cocaine,
heroin, barbiturates
and amphetamines.
Inquiry about drug
use is routine
clinical procedure.

Period
prevalence rates
calculated for
drug use.

Wide differences in
period prevalence
between marijuana
and cocaine, with the
percentage revealed
in personal interview
28.7% and chart
review 7.5%.

VI

Marijuana use
revealed almost 4
times as often in
interview vs chart
review.

Discrepancies
Between
Women’s
Personal
Interview Data
and Medical
Record
Documentation of
Illicit Drug Use,
Sexually
Transmitted
Diseases, and
HIV Infection

36

The first 301
women to
deliver had
data
abstraction
from charts.

Chart
review.
Urine
toxicology
done if drug
use
suspected
and may be
repeated
during
pregnancy.

Medical record
documentation,
nurses and
physician notes or
toxicology screens
for marijuana,
cocaine, and
heroin.

Positive
agreement
between
interview and
chart review
were determined
by positive
reports matched
between both
sources and
Kappa statistics
were used.

Cocaine showed the
greatest agreement
with 12.2% revealed
in interview vs 18.6%
in chart review.
Heroin use was
documented in
medical chart more
frequently (9.7%)as
compared to
interview (5.8%), but
this was not a
significant difference.

Limitation:
Information about
illicit drug use was
collected at 2nd
interview. Drug use
included last 12
months in interview,
chart review was for
length of pregnancy.
1/2 women responded
for >/=6 months of
pregnancy, the other
1/2 for the period that
included </=5 months
of pregnancy.
Rec that labs alone not
be used for evaluation
of illicit drug use.

36

Citation

Design/
Method

Sample/
Setting

Major
Variables
Studied and
Their
Definitions

Outcome
Measurement

Data
Analysis

Findings

Level of
Evidence

Quality of Evidence:
Critical Worth to
Practice

(Ostrea et al.,
2001)

Descriptive/
Maternal
interview
Toxicology of
hair and
meconium

75 women
from a
convenience
sample of all
women who
presented for
prenatal care
at the Hutzel
Hospital
antenatal high
risk clinic
enrolled.

Maternal
interview via
questionnair
e on first and
subsequent
visits,
scripting
used re: use
of cocaine,
opiate and
cannabis.

Amount and
frequency of each
substance used,
cocaine, opiates
and cannabis
revealed by selfreport

3 methods of
detection
compared btwn
12 and 40 weeks
gest age.

Interview had lowest
sensitivity for
detection of cocaine
(65%) and opiate
(67%) use, but
highest sensitivity for
cannabis (58%).

VI

Interview has highest
sensitivity for
cannabinoids
compared to
meconium or hair
analysis.
Interview has a high
degree of agreement
with hair and
meconium analysis for
detection of cocaine
and opiate use.

Estimates of
Illicit Drug Use
During
Pregnancy by
Maternal
Interview, Hair
Analysis, and
Meconium
Analysis

37

Final sample
of 58 mothers
and 59 infants
(one set of
twins)

Maternal
hair sample
for drug
analysis for
cocaine,
opiate, and
cannabis

Infant
meconium
analyzed for
cocaine,
opiate, and
cannabinoid

Pencil shaft sized
hair sample from
mother. Analysis
by radioimmunoassay with Gas
chromatography/
mass spectroscopy
(GC/MS)
Sample obtained
from newborn and
analyzed for
cocaine, opiates,
and cannabinoid.
Analysis by
radioimmunoassay. Positive
results confirmed
by (GC/MS)

37

Degree of
agreement btwn
positive results
for 3 methods
evaluated using 2
way & 3 way
kappa statistics.
Sensitivity and
specificity
determined by
comparing one
positive with the
other two
methods for
reference.
Reference was
positive if either
ref method was
positive.
Negative if both
reference
methods were
negative.

Hair analysis had
100% sensitivity for
cocaine, but a false
positive rate of 13%.
80% sensitivity for
opiate detection, 20%
false pos.
Meconium had
sensitivity of 87% for
cocaine, no false
positive.
Sensitivity for opiates
of 77%.
High degree of
agreement (p<0.001)
among the 3 methods
for detecting cocaine
and opiate use
(Cohen’s kappa =
0.452-0.840)

All interviews done by
the same person
Infants born to drug
using women were
significantly small for
gestation and
significantly lower
birth weight

38

a tendency toward mothers who received home visits to be more engaged in drug
treatment services, but further studies were needed (Turnbull & Osborn, 2012). Table 3
reflects behavior change studies.
Aim statement
By July 2014, community health workers will use the 5P’s substance use
screening tool in greater than or equal to 90% of initial prenatal visits.
Recommendation for practice change
A substance abuse screening tool that is made for pregnant women, with a focus
on risk, not just heavy use, is ideal. The tool used for screening pregnant women needs to
address past behavior as an assessment of risk, and not solely screen for current behavior.
Women with a history of previous use of alcohol or cigarette use should benefit from a
brief intervention that warns them of the consequences of beginning use again while
pregnant. The best tool is one that is used consistently and reveals light or intermittent
use as well as regular use of substance(s) and is easy to use (Chasnoff et al., 2005). Table
4 compares the substance use screening tools reported in the literature.
Therefore, the 5P’s screening tool was the ideal substance use screening tool for
this evidence based practice improvement project. The 5P’s substance use screening tool
is based on a validated tool, combines indirect and direct questioning, which has been
shown to reveal more substance use than either direct or indirect questioning alone. The
5P’s was designed for use with pregnant women, has been shown to be easy to use by
prenatal office staff, and was used in more than 90% of initial interviews in one study
(Kennedy et al., 2004). The 5P’s substance use screening tool is designed to assess risk
as well as use, and this leads to a brief intervention by the community healthcare worker
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Table 3. Behavior change studies
Citation

(Chang et al., 2011)
Self-Reported Alcohol and
Drug Use in Pregnant
Young Women: A Pilot
Study of Prevalence and
Associated Factors

Design/
Method

Crosssectional
study
Survey
followed
by
interview

Sample/
Setting

30
pregnant
young
adults up
to age 25

Major Variables
Studied and
Their Definitions

Outcome
Measurement

DSM-IV substance
use disorder
module

Self report of
drug and
alcohol use as
well as the
context within
which the
alcohol or drugs
would be used

Drinking within the
six months prior to
the interview

Data
Analysis

Findings

Level of
Evidence

Drinking in
settings: intimate,
socially, and
negative coping

Descriptive
statistics using
percentages,
means and
standard
deviations.
Fisher’s exact
test to compare
demographics
Wilcoxon’s
test

39

Likelihood of
behavior change

Logistic
regression to
measure the
area under the
curve

90% of women were
single
While pregnant:
8 (27%) drank
average of 1.8
drinks/day (4% of
days were drinking
days).
3 (10%) smoked an
average of 4.3
marijuana cigarettes
on days they
smoked (88% of
days).
1 woman used both
alcohol and
marijuana
7 women fit DSMIV criteria for
lifetime alcohol use
disorders, 1 had a
current disorder.
9 met criteria for
lifetime cannabis
use disorder.

40

VI

Quality of
Evidence:
Critical Worth
to Practice
Pre-pregnancy
alcohol and
cannabis use
was associated
with prenatal
alcohol and
cannabis use.
Small sample
size limits
generalizability.
No women
indicated they
would change
behavior based
on the
interview alone,
leading the
authors to
recommend
brief
intervention or
counseling.

Citation

Design/
Method

Sample/
Setting

Major Variables
Studied and
Their Definitions

Outcome
Measurement

Data
Analysis

Findings

Level of
Evidence

Quality of
Evidence:
Critical Worth
to Practice

Clark, Dawson, & Martin,
(1999)

Randomiz
ed
controlled
trial

200
women
screened
with “old”
procedure

“old” screening
approach – three
check boxes for
substance use, one
for
smoking/alcohol,
and one for drug
use, one for drug
addiction/alcoholis
m

Any alcohol,
cigarette or drug
use.

Relative risk,
confidence
intervals.

21% of women with
old procedure
reported smoking/
drinking alcohol

II

More detailed
questions
improves
reporting as
compared to
yes and no
questions

The Effect of
Implementing a More
Comprehensive Screening
for Substance Use Among
Pregnant Women in North
Carolina

400
women
screened
with
“new”
procedure

“new” screening
approach-more
detailed questions
re: frequency of
cigarette, alcohol,
and illegal drug use
during pregnancy

Further
information
regarding
frequency and
amount of
alcohol,
cigarettes and/or
drug use

76% of women
screened with new
procedure reported
smoking/drinking.
Able to separate to
61% smoked
43% drinking

Separation with
new procedure
of alcohol and
smoking

12%drug use with
old screen
18% with new
screening

40

no women revealed
drug addiction or
alcoholism with old
screen, 6% detected
with new screen

41

43% of women
who revealed
substance use
or abuse may
have been
missed with old
screening
procedure

which is a discussion about the importance of abstaining from alcohol, drugs and tobacco while
pregnant. As well, if actual use is admitted, motivational interviewing is used as part of the brief
intervention to discuss the pregnant mother’s feeling as to whether she can change behavior at
the time of the interview. The 5P’s screening tool also assesses the associated factors with
substance use such as family violence. Appendix C shows the 5P’s substance use screening tool
and Appendix D shows the permission to use the 5P’s substance use screening tool.
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Table 4. Substance use screening tools comparison
Tool

Length
of use

T-ACE

Assesses
drugs

Assesses
alcohol

4 items

No

TWEAK

5 items

AUDIT-C

3 items

ASSIST

5P’s

8
question
(follow
up –
lengthy)
5
question
s (brief)
Brief

CAGE

4 items

Revised CAGE:
Alcohol
(Midanik,
Zahnd, & Klein,
1998)

4 items

4 P’s Plus

Time period for
assessment

42

Assesses
associated
factors
ie: tobacco,
violence
No

Cost for
Use

Sensitivity and
Specificity

Yes

Developed
or for use
for
pregnant
women
Yes

Free

Heavy use

No

Yes

Yes

No

Free

No

Yes

Yes

No

Free

not for prenatal
patients

Yes

Yes

No

Tobacco

Free

High sens for heavy
drinking
67-95% Sens
85% Spec
Pos pred value 92100%
54-97% sens
50-96% spec

Direct/ ind quest.
prior to & during
preg
Ind/direct questions
prior to preg &
current use

Yes

Yes

Yes

No

Yes

Yes

Yes

Tobacco,
violence

Cost for
use –
permission
Free with
permission

No

Yes

No –
developed
for men

No

Not rec for pregnant
women

No

Yes

No, but has
been used
with
pregnant
women

No

Sens <20 y.o. 12-73%
>/= 20; 57-84%
>=20; 84-92%
Spec 91-99%

12 months prior to
pregnancy
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87% sens
76% Spec
Assessment ongoing

Length
of use

Time period for
assessment

Assesses
drugs

Assesses
alcohol

Yes

Developed
or for use
for
pregnant
women
Yes

Assesses
associated
factors
ie: tobacco,
violence
No

Modified
CAGE:
Drug use
(Midanik et al.,
1998)

4 items

12 months prior to
pregnancy

No

Drug Use
Disorder (DUD)
Questionnaire
(Scherer et al.,
2013)

12 items

Previous 12 months

CRAFFT

6 items

Lifetime use
addressed

Cost for
Use

Sensitivity and
Specificity

Yes

No

No

No

Assesses for drug use
and dependence, not
for risk of use

Yes

Yes

No

Used in one study;
embedded in health
questionnaire.

Yes –
THC only

Yes

Validity/Re
liability in
pregnant
population
not
ascertained
.
Yes

Sensitivity lighter drug
use <20 year old 1037%
>/=20; 34-37%
THC24-30%
20 and older 23-25%
heavier drugs < 20
year old 31-80%
>/=20; 84-92%
Spec 91-99% for all
groups/ages
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Tool

(Braaten et al.,
2008)

Substance Use
Risk pregnancy
Profile

5 items
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No

Free

91% sens
67% spec

III. IMPLEMENTATION
Project Setting/Population
The setting chosen for this evidence based practice project was the Clark County
Public Health Department’s Healthy Mommy Healthy Baby, Help Me Grow and Healthy
Families America programs. These programs serve almost 300 pregnant and postpartum
women in Clark County, located in Southwest Ohio. The three prenatal and postpartum
programs provide pregnant women between one and five prenatal visits. See Appendix E
for the agency permission form.
Healthy Mommy Healthy Baby serves primarily African American women, teens
and Hispanic women, from the prenatal period until the toddler is two years old. The
Help Me Grow program serves first time mothers whose babies are less than six months
old through the age of three years old. The Healthy Families America program serves
women during the prenatal and postnatal period, and until the child is five years old.
Table 5. Clark County Health department Programs
Program Title
Healthy Mommy
Healthy Baby

Help Me Grow
Healthy Families
America

Maternal
population served
Aimed at African
American women,
pregnant adults and
teens
First time mothers,
no race limitations
No race limitations,
pregnant women
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Child population served
Fetus to two years old

Less than six months to two years old
Fetus through five years old

All programs serve those women, babies, and children found to be below 200% of
the poverty level and eligible for Medicaid services. In addition, those served include
teen mothers, transient or homeless individuals and women with unintended pregnancies.
The aforementioned programs in Table 5 fall under the Child and Family Health
Services Program at the Ohio Department of Health. Staffing at the programs consisted
of registered nurses, licensed social workers, and certified community health workers.
The programs function to assist clients to incorporate life-changing behaviors and
collaborate with other agencies for referrals with an overall aim of improving pregnancy
and infant outcomes.
Upon admission to any of the three programs, the staff completed an initial intake
form that asks each pregnant woman questions regarding tobacco, alcohol, and illicit drug
use. At the time of the evidence based practice improvement (EBPI) project
implementation, there was no standard evaluation tool to elicit information related to the
use of alcohol, tobacco, or illicit drug use upon entry into any of the above mentioned
maternal/infant health programs. Each staff member asked questions as to substance use
as they saw fit, and checked three boxes that the subject of alcohol, tobacco, and illicit
drugs had been discussed. For instance “I know you probably don’t use drugs, but I have
to ask” or “Sorry we have to ask, but you don’t use drugs, do you?” Questions about
alcohol and tobacco were asked in a similar manner.
If substance abuse was revealed, the drug treatment facility to which clients are
referred is the McKinley Hall Women’s and Children’s Program. Inpatient and
outpatient therapy are available at McKinley Hall’s Program for women with substance
use problems (C. Parker, personal communication, September 2013). Outcomes of the
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referral were not tracked at the beginning of the EBPI project, but anecdotal evidence
suggested that women who disclosed substance use and sought treatment in Clark County
had been treated by McKinley Hall and some took maintenance medications at the time
of delivery (C. Parker, personal communication, September 2013). Pregnant women
typically were given priority if inpatient treatment was needed (M. Walsh, personal
communication, January 2014). Participation in any of Clark County’s prenatal programs
is voluntary and the relationship was based on mutual trust. If a woman disclosed
substance use, a referral may be made, but the mother was not obligated to follow
through with the referral. Care and support continues to be provided by the certified
community health workers (CCHW), nurses and social workers regardless of the
mother’s participation in a substance use treatment program (C. Parker, personal
communication, September 2013).
Implementation plan
The team involved in implementation of the EBPI project is listed in Table 6. The
team was responsible for planning training times, obtaining contact hour credit, providing
training on the standardized training tool, and providing printed material about substance
use in pregnancy.
The DNP student project leader coordinated the education time, contact hour
preparation and approval, IRB application, data collection and data analysis. The
manager of the Healthy Mommy Healthy Baby program and Director of the Clark
County Maternal/Child Division met with the DNP project leader multiple times over the
year prior to implementation to provide information and facilitate a smooth
implementation plan. Dayton Children’s Hospital employees sponsored the contact hour
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preparation and approval as outreach education. The biostatistician provided statistical
support for the DNP student after data collection and completion of the project.
Table 6. 5P’s Screening Implementation Team
Name

Role

Agency

Lisa R Jasin

Project leader/DNP student

Wright State University

Carlissa Parker

Leader Healthy Mommy Healthy
Baby

Clark County Public Health

Lori Lambert

Director, Clark County
Maternal/Child Division
Certified Community Health
Workers, nurses and social workers

Clark County Public Health

Mary Ann Swank

Contact Hour preparation

Dayton Children’s Hospital

Caroline Michael

Contact Hour Approval

Dayton Children’s Hospital

Michele Walsh

Advisor

Ohio Children’s Hospital
Neonatal Abstinence Working
Group

Rick McLead

Advisor

Ohio Children’s Hospital
Neonatal Abstinence Working
Group

Adrienne Stolfi

Biostatistician

Clark County Public Health

Wright State University and
Dayton Children’s Hospital

Plan Do Study Act. Plan Do Study Act (PDSA) is a method of testing a change.
PDSA is the implementation step in Levin’s EBPI model. The Plan step is the plan
needed to test the change. The Do stage is carrying out the plan of change. Study
indicates observation of results of the test of change and reflection on what was learned
during the Do stage. Act is the step in which changes are made and preparation is made
for the next PDSA cycle. The first PDSA cycle is typically tested on a small group in a
real world setting on a small scale called a small test of change. After the first PDSA
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cycle, the next PDSA cycle is performed based on the outcome of the small test of
change. The subsequent PDSA cycles may be expanded to other parts of an organization
or implemented on a larger scale (Institute of Healthcare Improvement [IHI], 2014).
Readiness for Change
Barriers. Overcoming skepticism and misperception was the biggest barrier to
implementing change. Melnyk & Fineout-Overholt, (2011) discuss skepticism and
misperception as a major barrier to any implementation of an evidence-based practice
change. The Clark County Public Health staff, which included CCHW, social workers,
and registered nurses (RNs), were open to changing their substance use data collection
tool and providing information, but not necessarily the time commitment required to
perform a new screening and brief intervention with clients.
During clinical time previously spent with the CCHW, the DNP student had
informal conversations about screening for substance use in the prenatal population. The
comments made by the CCHW included "It's hard to find time to fill out more
paperwork" (community health workers, personal communication, September, 2013).
During the education session, the CCHW were trained with the 5P’s substance
use screening tool using self-directed role-playing. Role playing is a process of active
learning by which participants are immersed in the process being taught. The participants
gain understanding and skill in the use of the tool when engaged in active learning as
opposed to passive learning in which the participants are expected to absorb and
memorize pre-processed information. Active learning provides a higher level of
engagement and motivation in participants, which was evident during the role playing
session (McCarthy & Anderson, 2000).

49

The CCHW self-selected pairs and each performed the role-playing exercise with
peer evaluation and then switched roles. Role-playing demonstrated the rapidity with
which the 5P’s substance use screening tool could be used in the context of patient
screening. Appendix F refers to the role playing script and the peer evaluation of the
education that was provided.
Facilitators. The manager of the Healthy Mommy Healthy Baby program had
buy in for the project, through previous conversations and education provided to the
Clark County Public Health staff regarding the implementation of the 5 Ps screening tool.
The Director and manager voiced support for instituting consistent evaluation for
substance use of clients at entry into any of the three programs.
There was one community health worker from the Clark County Healthy Mommy
Healthy Baby program who expressed a positive attitude at the thought of having a
consistent method to document the substance use assessment. This individual was the
unit champion, was an informal leader, and was the person with the most seniority in the
Healthy Mommy Healthy Baby Program. The unit champion provided support for fellow
staff members and distributed information in the form of pamphlets for clients that were
provided by the March of Dimes and Centers for Disease Control. Pamphlets were
distributed to the staff by the unit champion to use during the implementation of the new
5 Ps screening process. However, a behavior change in the staff was not noted with the
distribution of pamphlets, but did result in reinforcement of information previously
discussed with the staff.
The Clark County prenatal programs serve approximately 300 pregnant and
postpartum women. Entry into any of the three programs was primarily by word of
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mouth. It was anticipated that between ten and twenty women would enter the three
programs in a month (C. Parker, personal communication, September 2013). Therefore,
the first two weeks of the new implementation by the Healthy Mommy Healthy Baby
program were expected to include three to five pregnant women. The initial two weeks
encompassed the first PDSA cycle.
Methods
The DNP student received training regarding the 5P’s screening tool for substance
use in February 2013. The trainer was Enid Watson, Director of Screening and Early
Identification, Massachusetts FASD State Coordinator, Institute for Health and Recovery.
The DNP student provided the two-hour education program for CCHW, RNs and social
workers. There was one education contact hour available for all who attended, provided
by the local Children’s Hospital. The education method was a PowerPoint (Appendix G)
lecture and a role playing activity. During the role-play, participants were able to use the
5P’s screening tool for assessing substance use and practice the discussion/intervention if
risk of substance use was identified.
The EBPI project began with a training session for RNs, social workers and
certified community health workers. Because of the barrier of time to commit to training,
the entire staff from the three prenatal and postpartum programs were trained at the same
time.
The PowerPoint used to educate the Clark County staff members contained
history of the 5P’s substance use screening tool, Screening, Brief Intervention, and
Referral to Treatment (SBIRT), and information about motivational interviewing. The
role-playing activity took place between pairs of staff, one of whom played the part of the
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pregnant mother, and the other who played the part of the interviewer. Peer evaluation
took place using the tool in Appendix E to ensure all areas of the SBIRT process were
addressed. After the first role-playing exercise, the staff members then switched roles.
While the DNP student provided the initial training, subsequent training sessions were
conducted by peer-to-peer teaching. The PowerPoint (Appendix G) and peer evaluation
tool (Appendix F) was made available to the Clark County prenatal and postnatal staff
after the initial training period to ensure consistency of the program.
Plan Do Study Act. The initial Plan Do Study Act (PDSA) cycle (small test of
change) occurred with the certified community health workers from the Healthy Mommy
Healthy Baby (HMHB) staff. The initial PDSA cycle and data collection occurred for
two weeks. The plan proceeded as expected, with fewer than expected pregnant women
entering the HMHB program. As well, one of the CCHWs used the 5P’s substance use
screening tool with clients already in the program as opposed to new clients. This
specific CCHW felt more comfortable using the screening tool with patients already
enrolled in the program versus patients that were initial intakes. The DNP student
learned of this unintentional change in protocol while talking with the CCHW during a
data collection appointment.
The prediction the DNP student made for the first PDSA cycle was that there
would be a change in substance use or violence risk revealed with the 5P’s substance use
screening tool as opposed to free form questioning. During the first PDSA cycle, three
CCHW’s saw three new intake clients. The DNP student predicted the CCHWs would
find the 5P’s substance use screening tool easy to use, which was stated by the CCHW
during the first data collection session. During the first PDSA cycle, one pregnant
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woman who was a current client revealed a risk factor for substance use on follow up
when the CCHW used the 5P’s substance use screening tool for follow up, that was not
revealed in the initial intake with free form questioning.
The second PDSA cycle was extended to the Healthy Families America program
with no changes and continued for three total months of data collection. Figure 2 shows
the timeline for the EBPI project. Appendix H shows the two PDSA cycles.

Figure 2. Timeline for Evidence Based Practice Project

Prior to beginning the staff education program, a pre-survey was given (Appendix
I). Immediately after the staff education program, a post-survey was given (Appendix I).
As questions included intent to use and ease of use, the immediate post-survey was used
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to assess and compare the intent to use the 5P’s substance use screening tool immediately
after the staff education session as well as the perception of ease of use. After the staff
had the opportunity to use the 5P’s screening tool for two months, the post-survey was
administered again to assess and compare ease of use, and continued intent to use the
5P’s screening tool (Appendix I). The staff members who took the pre survey and
immediate post survey were the same staff members. However, the staff members who
took the post survey eight weeks after the education program were not all the same staff
members who took part in the pre and post survey due to staffing changes.
Staff were instructed that if substance use was revealed by the expectant mother, a
brief intervention was to be performed with the staff member stating the need for
abstinence and/or treatment for the substance use. If the disclosure consisted of illicit
substance use, referral was supposed to be made to McKinley Hall Treatment Center and
the woman was encouraged to disclose the substance use information to the obstetrician.
Both of these actions on the part of the pregnant woman were voluntary.
Each staff member was given a tool kit which contained a copy of the 5P’s
screening tool for substance use and pamphlets from the March of Dimes and the Centers
for Disease Control that consisted of information about alcohol, tobacco and illicit drug
use in pregnancy. The pamphlets were given to all expectant mothers. However, if risk
of substance use was revealed, the written information was to be accompanied by verbal
discussion initiated by the CCHW, RN or social worker. The pamphlets from the March
of Dimes were “Alcohol and Pregnancy”, “Smoking and Pregnancy” and “Drugs and
Pregnancy.” Each of these pamphlets detailed the effect of alcohol, tobacco and drugs on
the fetus. The Centers for Disease Control pamphlet was “Think Before you Drink” and
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detailed prevention of Fetal Alcohol Syndrome. Included in the tool kit was also a copy
of the power point lecture (Appendix G) for reference.
The DNP student accomplished retrospective data collection of client
demographics to include race, age, number of pregnancies, number of living children,
weeks of pregnancy, education, and intent to breastfeed. The DNP student also collected
data to include use of the 5P’s substance use screening tool, risk revealed, referrals for
treatment for substance use or domestic violence, and documentation of discussion about
substance use or documentation of written information about substance use being given,
for the three months prior to implementation after IRB approval. Data collection for
intake interviews after implementation was accomplished on an every other week basis
(Appendix J).
The expected outcomes of increased use of a standardized screening tool for the
identification of risk for substance use while pregnant was expected to lead to an
increased discussion of abstinence of substances while pregnant. The data collection
included whether the 5P’s screening tool or the “old” tool was used in the initial
interview, whether risk was identified, if referral was made, and documentation of brief
intervention, discussion and written information took place.
Instruments
Staff pre and post survey. Outcome measures included both staff and client
outcomes. Staff was surveyed prior to education in the use of the 5P’s substance use
screening tool and immediately following the education (Appendix I). The staff was
surveyed with the same questions two months after education, which allowed the staff
time to use the 5P’s substance use screening tool with clients at intake appointments.
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The staff included certified community health workers (CCHW), social workers
and nurses. Staff were surveyed prior to the staff education session to determine the
baseline knowledge about the 5P’s substance use screening tool. Then the staff were
surveyed immediately following the staff education session to determine the change in
knowledge about the 5P’s substance use screening tool. Lastly, the staff were surveyed
(Appendix I) eight weeks following the initial staff education session to determine if the
change in knowledge about the 5P’s substance use screening tool was retained. The staff
surveyed at eight weeks after the staff education session may not have been the original
staff members who received the education due to staffing changes.
The DNP student created the pre and post survey tool used with the staff. The
questions used by the Institute of Health and Recovery in previous evaluations of the 5P’s
substance use screening tool were not available. However, Enid Watson, from the
Institute of Health and Recovery, discussed the themes of the questions during the DNP
student’s training in the use of the 5P’s substance use screening tool. The themes were
used to develop nine questions and a Likert scale was used as a response. The Likert
scale of 1 indicated strong agreement with the statement, and 5 indicated strong
disagreement with the statement. There was no established validity or reliability for the
DNP created pre and post education survey tool.
The staff survey consisted of nine questions along four themes. The themes were
knowledge, ease of use, comfort level, and intent to use the tool. The knowledge
questions asked if the staff knew what the 5P’s substance use screening tool was, if the
staff knew how to use the tool, and if the staff knew what to do if a mother had a positive
screen. The ease of use question asked the staff if the 5P’s substance use screening tool
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was easy to use. The comfort questions asked if the staff was comfortable asking the
questions on the 5P’s substance use screening tool, if the staff was comfortable
questioning a pregnant woman about substance use, and if the staff was comfortable
performing a brief intervention. The intent to use question asked if the staff planned to
use the 5P’s substance use screening tool at intake interviews. See Appendix I for staff
evaluation tools.
There were a total of nine questions with an individual score of a minimum of 1
and a maximum of 5. Therefore, the total score would be a minimum of 9 and a
maximum of 45. The lower score indicated a positive response and was more desirable.
All questions were asked in a positive fashion with strong agreement (score of 1) as the
goal. The change in score of each individual question that was desired from the pre
survey to the post survey was an increase in agreement and thus a score on each
individual question closer to 1 and a total score closer to 9.
Staff role playing and peer evaluation. The staff revealed a concern for the
time it would take to perform the 5P’s substance use screening tool. To demonstrate the
rapidity with which the 5P’s substance use screening tool could be used, the DNP student
planned a role playing session. The staff practiced role playing in self-selected pairs and
used a checklist that was created to ensure all the steps of the 5P’s substance use
screening tool were followed. Both members of the pair were given the opportunity to
play the role of the pregnant woman and of the interviewer. The role of the pregnant
mother provided answers to each question on the 5P’s substance use screening tool and
the checklist provided a place to check off each step of the screening process. Appendix
E shows the role playing and peer evaluation tools.
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Client Outcomes. Client outcomes were obtained for the three months prior to
implementation of the 5P’s substance use screening tool. Client outcomes were collected
by retrospective chart review every other week for three months after implementation of
the 5P’s substance use screening tool. The client outcomes were collected for the
Healthy Mommy Healthy Baby program initially for two weeks (during the first PDSA
cycle) and then implementation and data collection was expanded to all three prenatal
programs in the second PDSA cycle. Outcomes collected were de-identified and
included demographic data to include race, age, number of pregnancies, number of living
children, weeks of pregnancy, education, and intent to breastfeed, documentation of use
of the standardized screening tool, identification of risk for substance use and
documentation of discussion about identified risk for substance abuse. See Appendix J
for the data collection tool.
IRB
The Wright State University Institutional Review Board was approached for
expedited review for the EBPI project. In any intervention there are risks and benefits to
participation. Risk to clients was non-existent from a health standpoint. However, there
was potential risk related to privacy issues in relation to clients who were identified as at
risk for substance use. The privacy risk to any one client was decreased by deidentification of all data at the time the data was collected. The risk to staff members was
a potential loss of privacy if the answers to the pre and post surveys were revealed. The
risk of privacy was decreased by de-identification of pre and post surveys at the time of
the staff education session and again at the eight week post survey session.
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The benefit to client participants included possible decrease in health behaviors
that contribute to preterm birth. As well, there was potential for a possible increase in
client referral for cessation services concerning alcohol, tobacco and illicit drug use
related to increased assessment and discovery. The benefit to staff members included
possible improvements in future education based on the changes in the response to pre
and post survey questions. IRB approval for data collection is found in Appendix K.
IRB declaration of staff survey as quality improvement not requiring oversight of the IRB
is found in Appendix L.
Project Costs
Financial resources needed to implement the EBPI project required minimal
funding, see cost projection Appendix M. Personnel resources included the Clark County
Public Health Director, and Healthy Mommy Healthy Baby manager. There were no
personnel needed to perform the data collection, data entry, or staff training since the
DNP student performed these duties. Data analysis, review of integrated screening tool
and data advice was provided free of charge by a biostatistician who is an employee of
Wright State University. The March of Dimes and Centers for Disease Control provided
the educational handouts free of charge.
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IV. PROJECT EVALUATION
Outcomes of Project
Outcomes of the evidence based practice improvement project were measured in
three categories. The first outcome was measured by staff pre implementation, and post
implementation survey. The second outcome measure was peer evaluation in
combination with a role playing exercise. The third outcome measure was a measure of
the 5P’s substance use screening tool use and risk revealed related to its use. Statistical
significance was defined as p<0.05.
Staff pre and post implementation survey. The total score of the staff survey
could range from nine to 45, with a lower score indicating agreement with the survey
statements. The mean total score of the staff pre survey was 27. The mean total score of
the immediate staff post survey was 14. A paired samples t-test was conducted to
evaluate whether the pre test results with a range of 9 to 42 (M=27.12, SD=11.29), were
significantly greater than the post test results with a range of 9 to 42 (M=14.81,
SD=9.99), t (15) =4.25, p<.001. The paired sample t-test demonstrated statistical
significance in the change of total score on the staff survey from pre survey to immediate
post survey.
The staff post survey eight weeks after implementation demonstrated a continued
improvement in individual mean scores when compared to the pre survey mean scores
and the immediate post survey mean scores. The knowledge of the 5P’s substance use

60

screening tool decreased from a mean score of 3.3 on the pre survey to a mean score of
1.43 on the post survey. The mean score on the eight week post survey was 1.75 which
remained lower than the pre survey. The question that addressed comfort asking the
questions on the 5P’s tool demonstrated a decreased mean score from 3.12 on the pre
survey to 1.56 on the post survey and remained lower than the pre survey on the eight
week post survey at a mean score of 1.75. Comfort with questioning a pregnant woman
about substance use indicated a mean score of 2.25 on the pre survey and a decreased
mean score of 1.62 on both the immediate post survey and the eight week post survey.
Knowledge of how to use the 5p’s tool for screening for substance use decreased from a
mean score of 3.5 on the pre survey to a mean score of 1.87 on the immediate post survey
and showed further decrease to a mean score of 1.75 on the eight week post survey.
Planning to use the 5P’s tool on the pre survey showed a mean score of 2.5 which
decreased on the post survey to a mean score of 1.56. The plan to use the 5P’s tool mean
score increased to 1.87 on the eight week post survey. Knowledge of what to do if a
pregnant woman had a positive screen with the 5P’s tool had a mean score of 3 on the pre
survey and decreased to a mean score of 1.56 on the immediate post survey and an
increase to a mean score of 2.12 on the eight week post survey. Confidence in using the
5p’s screening tool had a mean score of 3.25 on the pre survey and a mean score of 1.75
on the post survey. The mean score increased to 2 on the eight week post survey.
Comfort performing a brief intervention had a mean score of 1.75 with no change in
mean score post survey and an increased mean score of 2 on the eight week post survey
results. Table 7 shows mean scores and standard deviation of staff pre and post surveys.
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Table 7. Staff Member Survey Change pre and post implementation
Pre implementation
Mean (SD)
N=16

Post implementation
Mean (SD)
N=16

I know what the 5Ps
screening tool is

3.3 (1.62)

1.43 (1.2)

8 weeks post
implementation
Mean (SD)
N=8
1.75 (.88)

I am comfortable
asking the questions
on the 5Ps tool

3.12 (1.58)

1.56 (1.2)

1.75 (.88)

I am comfortable
questioning an
expectant mother
about substance use

2.25 (1.23)

1.62 (1.02)

1.62 (.74)

I know how to use
the 5Ps tool for
screening for
substance use

3.5 (1.59)

1.87 (1.25)

1.75 (1.03)

I plan to use the 5Ps
screening tool for
substance use at all
new intake
interviews

2.5 (1.31)

1.68 (1.25)

2.12 (1.24)

The 5Ps screening
tool for substance
use is easy to use

3.25 (1.43)

1.56 (1.2)

1.87 (1.12)

I know what to do if
an expectant mother
has a positive screen
with the 5P’s
substance use
screening tool for
substance use

3 (1.54)

1.56 (1.03)

2.12 (1.12)

I feel confident
using the 5Ps
screening tool

3.25 (1.48)

1.75 (1.29)

2 (.92)

I am Comfortable
performing brief
intervention

1.75 (1.48)

1.75 (1.29)

2 (.92)

Each statement in the survey was looked at individually to compare the pre and
immediate post survey. The distribution of answers was not in a bell curve, but was a
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skewed distribution. Therefore, an exact McNemar’s test was performed to determine
statistical significance of the number of staff members who changed from disagree on the
pre survey to agree on the post survey. The responses were rated with a five point Likert
scale; strongly agree, agree, neutral, disagree, and strongly disagree. The exact
McNemar’s test required changing all strongly agree and agree responses to agree, and all
strongly disagree and disagree responses to disagree. Neutral responses were counted as
missing data. Table 8 shows the results of the staff pre and post survey with statistical
significance.
The exact McNemar’s test determined there was a statistically significant
difference in the individual staff survey question “I know what the 5P’s screening tool
is?” pre- and post-implementation (p<.031). Several questions demonstrated close to
clinical significance. The questions concerning comfort asking the questions on the 5P’s
tool (p<.07), knowledge how to use the 5P’s (p<.063), ease of use of 5P’s (p<.063), and
knowledge of what to do with a positive screen (p<.063). The remainder of the
individual questions showed no statistically significant difference.
The staff was evaluated with a post survey eight weeks after the implementation
of the 5P’s substance use screening tool. The mean total score of the post survey was 17
with a standard deviation 8.23 (N=8) on the same scale of minimum nine and maximum
45. This was a decrease from the pre survey mean 27.12 with standard deviation 11.29
(N=16) and slightly increased from the immediate post survey mean of 14.81 with
standard deviation 11.29 (N=16).
Staff peer evaluation and role playing. Peer evaluation of the staff took place
during the education class when community health workers divided into pairs and
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performed evaluation of each other with a role playing exercise (Appendix F) involving
screening with the 5Ps tool, brief intervention and motivational interviewing. All
participants verbally stated comfort with the role-playing exercise and evaluation in pairs.
The staff members retained their role-playing exercise and evaluation papers.
Table 8. Staff Member Evaluation Results
Change from
disagree to agree
N-6

Change from
agree to disagree
N-0

Statistical
significance
P<.031

I am comfortable asking the
questions on the 5Ps tool

N-7

N-1

P<.07

I am comfortable
questioning an expectant
mother about substance use

N-2

N-0

P<.5

I know how to use the 5Ps
tool for screening for
substance use

N-5

N-0

P<.063

I plan to use the 5Ps
screening tool for substance
use at all new intake
interviews

N-2

N-0

P<.5

The 5Ps screening tool for
substance use is easy to use

N-5

N-0

P<.063

I know what to do if an
expectant mother has a
positive screen with the
5P’s substance use
screening tool for substance
use

N-5

N-0

P<.063

I feel confident using the
5Ps screening tool

N-5

N-0

P<.125

I am Comfortable
performing brief
intervention

N-4

N-0

P<.125

I know what the 5Ps
screening tool is
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Client evaluation. The prenatal programs enrolled seventeen new clients in the
three-month period following implementation of the 5P’s substance use screening tool.
The prenatal groups, when compared, were unequal in number. There were 43 women
enrolled as new intakes prior to implementation and 27 women enrolled after
implementation across the three groups. However, in light of the third prenatal group
declining to use the 5P’s tool, those clients were removed from statistical analysis. There
were 57 remaining clients for evaluation of use of the 5P’s within the first two prenatal
groups. Demographic data is demonstrated in Table 9. Site 1 was Healthy Mommy
Healthy Baby, which had a 100% population of African American women. This was
appropriate for this group due to the focus of Healthy Mommy Healthy Baby to target
African American women for enrollment.
Evaluation of the first prenatal program demonstrated three of eight intake
evaluations performed using the 5P’s substance use screening tool after the
implementation took place. This equates to a 38 percent use in the initial intake. There
were nine new clients in the second prenatal group, of which four had the 5P’s tool used
in the post implementation period. This equated to a 44 percent use rate post
implementation. Combined, there was a 47 percent use rate of the 5P’s tool after
implementation took place.
Data analysis of the first two combined prenatal groups was completed pre and
post education using Pearson Chi Square. There was a significant difference (defined as
p<0.05) between pre and post education when comparing the use of the 5P’s tool
p=0.022. There was not a significant difference in identification of risk pre and post
education (p=.654), substance use disclosure (p=.5), referral to treatment (p=.473),
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Table 9. Demographics of Clients
Demographics of clients in the first and second prenatal groups pre and post education
Pre implementation of 5P’s tool
Site 1
Site 2
N=26

N=14

Post implementation
of 5P’s tool
Site 1
Site 2
N=8
N=9

Caucasian

N=0 (0%)

N=6 (42%)

N=0 (0%) N=3 (33%)

African American

N=26 (100%) N=1 (7%)

N=7 (87%) N=1 (11%)

Gravida

2.7(1.52)

1.6(.89)

1.37(.51)

2.8(.44)

Mean (SD)

Para

.87(1.02)

1.3(.51)

.28(.48)

2.4(.89)

Mean (SD)

< 12 years

N= 5 (19%)

N=1 (7%)

N=3 (37%) N=1 (11%)

12 years or >

N= 21 (81%) N=6 (42%)

N=5 (53%) N=4 (44%)

Age

24(5.9)

24.3(4.8)

19.7(3.9)

22.5(2.1)

Mean (SD)

Weeks of pregnancy

21.4(8.7)

33.4(12.6)

19.4(9.6)

36.5 (10.4)

Mean (SD)

Marital status

N=21(81%) N=7 (50%)

N=8 (100%) N=3 (33%)

Single

N=3 (12%)

N=0 (0%)

Married

Subjects

Total 57

Race

Years of school

N=0 (0%)

N=1 (11%)

Planning to breastfeed
Yes
N=13 (50%)

N=2 (14%)

N=4 (50%) N=2 (22%)

N=7 (27%)

N=2 (14%)

N=1 (12%) N=1 (11%)

No

Numbers do not add up to 100% due to missing data

documentation of discussion or intervention (p=.109), or written information given to
clients (p=.908).
One of the certified community health workers decided to use the 5P’s tool as a
follow up with current clients after the implementation. This certified community health
worker had twenty total clients in the six months before and after the implementation,
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and two were new clients after the education session. Of the eighteen current clients,
sixteen were screened with the 5P’s tool after the education session. This equated to 80
percent use of the 5P’s tool overall for this particular certified community health worker.
Of the sixteen clients, nine clients had risk identified with the 5P’s substance use
screening tool. Of those, eight clients had risk identified with the 5P’s tool that was not
identified during intake. This equated to a risk identification with the 5P’s substance use
screening tool of 56% compared to 6% with free form questioning. The risk was related
to violence (n=2), parental use of drugs (n=2), and smoking (n=4). Post implementation,
there was an increase in documentation of discussion as well as increased documentation
of written information given. Table 10 shows data related to risk identification post
implementation with a single CCHW.
Table 10. Pre and post implementation risk identification of a single CCHW
Initial Intake
Use on follow up
visits
N=16
N=16
5P’s tool used
N=0
N=16 (100%)
Risk identified

N=1 (6%)

N=9 (56%)

Disclosure
substance use

N=0

N=0

Referral made

N=0

N=1 (6%)

Documentation of
discussion

N=4 (25%)

N=14 (88%)

Written information
given

N=12 (75%)

N=16 (100%)
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V. DISCUSSION
Findings from this evidence based practice improvement project were expected to
demonstrate increased use of a standardized screening tool after education in the use of
the tool. Increased use of the standardized screening tool was demonstrated and it was
statistically significant. A clinically increased revelation of risk at initial intake interview
was demonstrated after implementation, but this was not statistically significant.
Staff pre and post survey evaluation
Sixteen staff members participated in the pre-implementation education program
about use of the 5Ps substance use screening tool, motivational interviewing, and brief
intervention. The staff members were representatives of three separate departments of
the public health department that provide services for pregnant women. The staff
members were certified community health workers who were required to have a
minimum education level of a High School education, nurses who were licensed practical
nurses at a minimum, and social workers. A pre-survey and post survey were obtained
before and after the education session. A post survey was obtained again eight weeks
after the education session (Appendix I).
Eleven staff members took part in the post survey eight weeks after the education
and implementation. Of those, the two staff members who used the 5Ps substance use
screening tool in the first PDSA cycle had resigned and were not present. Of the eleven,
there were three staff members who were newly hired and who did not participate in the
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education program. Those three new staff members post surveys were not included in the
statistical analysis.
The mean total score decreased from the pre to the immediate post evaluation of
staff and was statistically significant. However, the individual evaluation showed a
difference only in the knowledge of what the 5P’s tool was. The remainder of individual
questions pre and posttest did not have a statistically significant difference. The
difference between significant and insignificant change was impacted by the small
sample size. Statistical significance for this project was defined as p< 0.05. Several
individual questions approached statistical significance with a p<0.1. These were the
questions related to comfort asking the questions on the 5P’s tool, knowledge of how to
use the 5P’s tool, ease of use of the 5P’s and knowledge of what to do if there was a
positive screen using the 5P’s tool. The difference between statistical significance and
lack of statistical significance in these questions was one staff member changing to agree
from disagree on the post survey.
Strengths. The staff members were very receptive to “anything that improves the
care we provide.” The Healthy Mommy Healthy Baby manager was responsible for that
quote and the statement was echoed by the remainder of the staff. The entire staff was
available for the education session prior to implementation of the 5P’s substance use
screening tool. The Director of the prenatal services arm of the Public Health
Department was supportive and ensured the education took place by scheduling it on the
day of a district meeting to ensure staff attendance.
This was the first documented use of the 5P’s substance use screening tool in a
home visiting population with staff members who were certified community health
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workers. Previously, the 5P’s substance use screening tool was implemented with private
and public health obstetrical services by nurses, physicians, nurse practitioners and
certified nurse midwives (Watson, 2010). This type of implementation may have been
impacted by reimbursement as noted by Enid Watson in “The Evolution and Application
of the 5P’s Behavioral Risk Screening Tool” (Watson, 2010). Screening for substance
use is part of the initial intake interview in all prenatal departments of the public health
department. Substance use screening in the public health department is not tied to
reimbursement and because CCHWs as well as nurses perform initial intake assessments
at the public health department, it was reasonable for the staff of the public health
department to use the 5P’s substance use screening tool. The CCHWs demonstrated the
ability to successfully use the 5 P’s substance use screening tool and expose risk in
clients that could then be addressed with brief intervention and referral.
Barriers. A small sample size limited statistical significance. Staffing changes
had a large impact on the sample size due to resignations and new hires. The pre and
post survey was not a validated tool, but did ask questions along the same themes as the
Institute for Health and Recovery had previously asked when implementing the 5P’s
substance use screening tool.
Further impact on statistical significance was due to one of the three prenatal
programs using the 5P’s substance use screening tool at the direction of the state
department of health. The staff that was already using the 5P’s tool was not calling it by
the same name. The Director who was helping the DNP student coordinate the education
and implementation was unaware that the tool was in use. There had been no training for
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the staff using the tool prior to its implementation approximately six months before the
education session offered by the DNP student.
Staff role playing and peer evaluation
The staff role-playing and evaluation was a successful way to have peers practice
using the 5P’s evaluation tool. The staff members self selected the pairs for the role
playing exercise. All staff present at the education session completed the role-playing
evaluation on the first attempt.
Strengths. The staff members immersed themselves in the role playing exercise
as evidenced by direct observation by the DNP student. Staff members stated comfort
with the use of the 5P’s substance use screening tool after the role playing exercise in
response to direct questioning by the DNP student. The staff members kept the role
playing exercise and evaluation checklist for future reference. Active learning in addition
to lecture encourages not only passive absorption of information, but application of new
knowledge for better recall.
Barriers. There was no formal documentation of success of the role playing
exercise. Successful completion was self reported via verbal response to direct
questioning after completion of the exercise. Staff stated comfort with performing the
brief intervention after the role playing exercise during the staff education session. Staff
also verbalized the referral center that a client would be referred to if the client revealed
illicit drug use. This stated comfort was consistent with the increased comfort found in
the Massachusetts ASAP Program after role playing exercises, scripting and knowledge
of the local referral center for substance use (Kennedy, et al, 2004).
Client evaluation
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The intent of the evidence based practice improvement project was to use a
standardized screening tool in the first prenatal intake evaluation. Data was collected
retrospectively for three months pre implementation and also for three months post
implementation. The first prenatal group only had data collection for two months post
implementation. This was due to the resignation of two of three staff members after two
months of data collection.
The second prenatal program was already using the 5P’s tool. However, the staff
was not using the tool as a prenatal screening tool, but within thirty days of the baby’s
birth. This defeated the purpose of the 5P’s screening tool as a prenatal screening tool.
This concern was discussed with the manager of the second prenatal program. However,
it was found to be at the direction of a state level government agency that the 5P’s
screening tool be used as a postpartum tool. The staff of the second prenatal program had
been using the 5P’s screening tool for several months, however, the staff had not received
previous education about the use of the 5P’s, brief intervention, or motivational
interviewing prior to the education offered by the DNP student. The third prenatal
program elected not to participate in the 5Ps screening for new clients, primarily because
they were closed to new clients during the project implementation time frame.
Evaluation of the use of the 5Ps screening tool compared to free form substance
use questions took place retrospectively every two weeks for three months after the
education. Comparison was made between substance use screening in the three months
prior to education and for the three months post education.
The staff of the prenatal programs did not achieve a 90% use of the 5P’s
screening tool after education during intake interviews. One certified community health
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worker achieved an 80% use of the 5P’s screening tool. This was not done on initial
intake, but primarily with clients who had previously had an intake interview. While not
the intent of the EBPI project, it showed that use of a standardized screening tool does
reveal more risk than use of free form questioning, and increases screening of clients in
this population.
There were two comments made by the certified community health workers in the
first prenatal program to the DNP student during data collection. Both certified
community health workers were present during data collection approximately one month
after the education session. The statements made were, it’s “a little more uncomfortable
with first time clients” and it’s “easy with clients you’ve been with for a while.”
There was a significant difference in the use of the 5P’s tool post education.
While the tool was not available for the first prenatal program prior to the education, the
second prenatal program did have the tool available for use. This does show an increase
in the use of the 5P’s tool post education. There was not a significant increase in risk
revelation, substance use disclosure, referral for treatment, documentation of discussion
or intervention, or distribution of written information. Small numbers of post education
clients impacted the data analysis.
There were an unequal number of participants pre and post education, almost
twice as many pre as post. When evaluating demographic data, totals in each category do
not add up to the total of 57 due to unavailable data during chart review. Race was
unequal pre and post implementation and was primarily African American. This was due
to the prenatal programs designated service population. There were a higher number of
pregnancies in the pre implementation population, but no statistical difference in the
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number of living children. There was no difference in the years of education, but pre
implementation, women were older. There was no difference in the marital status or
plans to breastfeed pre and post education.
Further impact on the use of the free form questioning and documentation may
have been impacted by the way in which documentation was accomplished. Evaluation
of the free form questioning used prior to the education session showed that community
health workers were required to flip a piece of paper to visualize the check boxes to
document free form questioning and then turn a six sided folder upside down to
document the discussion. The 5Ps standardized substance use screening tool was a one
page document that required no additional movement beyond turning a page to obtain
access to the documentation.
Unintended results. The certified community health worker who used the 5Ps
substance use screening tool as a follow up for current clients was the same certified
community health worker who made the statement it’s “easy with clients you’ve been
with for a while.” Of the twenty clients who this certified community health worker
interviewed, eight had no screening on intake, twelve clients had free form questioning
on intake. Sixteen of the clients had screening with the 5Ps substance use screening tool.
Seven of the clients with no previous screening were subsequently screened with the 5Ps
screening tool. Two of these clients revealed smoking that was previously unknown and
two revealed risk for substance use that was previously unknown. Of the thirteen clients
who were screened with free form questioning, ten were subsequently screened with the
5Ps tool. One client revealed risk for alcohol use, and domestic violence that was
previously unknown, this client was known to use tobacco, which was discovered with
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free form questioning. One client revealed domestic violence that was previously
unknown.
The use of the 5P’s substance use screening tool enabled referral to counseling for
domestic violence that would not have taken place if only the free form questioning had
been used. When the 5P’s substance use screening tool was used in the ASAP 2 project,
36% of the women on whom it was used had a positive screen and received a brief
intervention (Fogerty &Finkelstein, 2005). This is consistent with a 56% positive screen
in the clients in this evidence based practice improvement project. The low number of
clients in this study impacts the percentage with a positive screening, but it does indicate
a higher rate of risk being revealed with use of the 5P’s substance use screening tool.
Strengths. In this evidence based practice improvement project, use of the
standardized screening tool revealed a higher percentage of risk than use of free form
questioning, although this was not statistically significant. This is consistent with the
findings by Clark, Dawson, & Martin (1999) that free form questions reveal less smoking
and drinking than more detailed questioning. The small number of new clients who were
interviewed at intake impacted the statistical significance.
Barriers. There was a lower than expected number of clients who had intake
interviews post education. This was the result of several unanticipated variables.
The timing of the implementation of the 5P’s substance use screening tool
coincided with the 2014 grant cycle. At that time, there were changes made to several
programs and it was unclear what effect the grant approval or disapproval would have on
the third prenatal program that was planned to implement the 5P’s tool. This resulted in
closing of the third prenatal program to new intake clients.
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The first prenatal program that implemented the 5P’s tool had staffing changes
related to funding immediately prior to implementation and had a loss of the Spanish
speaking CCHW and stopped new client intakes of Hispanic women. The first prenatal
program shifted entirely to African American women in compliance with the grant that
funded the program.
The second prenatal program was already using the 5P’s screening tool; however,
it was being used as a postnatal screening as opposed to a prenatal screening tool. When
this was discovered, a discussion took place with the manager of the second prenatal
program. The manager reviewed the need for the 5P’s screening tool to be used prior to
the infant’s birth. Though there was not enough time to demonstrate a change in practice,
this is considered a positive outcome by both the manager of the second prenatal program
and the director of the public health department.
There were staffing changes in the first prenatal program, with one staff member
being down-sized immediately prior to education. Two of the remaining staff members
resigned two weeks prior to the completion of the three month post education data
collection.
Future Recommendations and Conclusion
The 5P’s substance use screening tool is able to be used successfully in a public
health setting by certified community health workers. Peer to peer role playing and
evaluation is a successful strategy to teach use of the 5P’s screening tool. Staff involved
in treating pregnant women benefit from education in motivational interviewing and use
of a brief intervention.

76

There was added value in using the 5P’s substance use screening tool in follow up
interviews with clients. Follow up interviewing using the 5P’s tool demonstrated
increased risk detection, increased documentation of discussion and increased
documentation of written information given. Further study with a larger sample size is
needed to determine the effect of the 5Ps tool on the prenatal population served by
community health workers.
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Appendix A
Permission to use Evidence-Based Practice Improvement Model by Author
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Appendix B
License to use Evidence-Based Practice Improvement Model by Publisher
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Appendix D
Permission to use 5P’s

Enid Watson
Institute for Health and Recovery
349 Broadway
Cambridge, MA 02139
December 9, 2013
Lisa Jasin
Wright State University
3640 Colonel Glenn Hwy
Dayton, OH 45435
Dear Ms. Jasin,
This letter acknowledges that you received training on the Institute for Health & Recovery 5 P’S
screening tool, and that you have permission to utilize it in the Alcohol, Tobacco and Illicit Drug
Screening in Pregnancy Project. We understand that the goal of the project is to standardize the
screening process in the public health department working with pregnant women. Certified
community health workers, RNs and social workers have potential to use the tool, but it will
primarily be certified community health workers. We applaud the implementation of the tool
with community health workers, in addition to the more traditional staff, and trust that all staff
will be trained in Brief Interventions, Motivational Interviewing, and develop a familiarity with
local substance use disorder assessment/treatment resources.
While we do not charge for the use of the 5 P’S, we ask that; 1) you submit your screening tool
to us for our files; 2) IHR is clearly cited on the form; and 3) that you submit unidentified data to
us on your outcomes.
Best wishes to you in your Doctor of Nursing Practice program. Please do not hesitate to contact
me should you have any comments.
Enid Watson, MDiv
Director, Screening & Early Identification Projects
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Appendix F
Education Role Playing and Peer Evaluation
Role Playing Exercise
Role of pregnant mother:
Parents drank alcohol, but didn’t have a problem
Several friends have a problem with alcohol
Partner does not have a problem with alcohol or drugs
No problems for you in the past with alcohol or drugs
Currently not using alcohol or drugs
Smoker of tobacco
No depression
No issues with violence

Role of interviewer:
State screening preamble
Review the 5P’s questions for risk
Assess: positive answer (Yes answer) according to 5P’s tool
Advise: Recommend abstaining – provide written information
Work with mother’s reaction
Motivational interviewing:
Ask open ended question? ie: What do you think you want to do about your use?
Affirming: recognize strength or behavior that leads to positive change
Ie: “I appreciate that you are willing to meet with me today” “You are a resourceful person”
Reflective listening: Use simple reflection, paraphrase or repeat emotional meaning
Summarize the major points of the conversation/interview
Develop a change plan

91

Peer Evaluation for 5P’s Substance Use Screening Tool/SBIRT
Interviewer_________________
Evaluator _________________
Instructions: Please take turns with your partner role playing using the attached scenarios. Role
playing will be done twice, with each person playing the interviewer once and playing the
pregnant mother once.
Please evaluate interviewer behaviors as a “Yes” or “No” based on whether they were performed.
Circle the appropriate response as the role playing progresses.

Behavior
Introduces self
Uses screening preamble
Asks questions from parents (nonthreatening) to present use (more
threatening)
Asks about smoking
Asks about emotional health
Asks about intimate partner violence
Assesses for risk
- Any positive response
Advises abstaining
Offers pamphlets
Uses open ended questions
Affirmation of mother’s ability to
make change
Reflects statements made by mother
Summarizes the major points
discussed
Develop a change plan and asks for
commitment:
What do you intend to do?

Yes
Yes
Yes
Yes

No
No
No
No

Yes
Yes
Yes
Yes

No
No
No
No

Yes
Yes
Yes
Yes

No
No
No
No

Yes
Yes

No
No

Yes

No
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Appendix G
Power Point presentation for staff education
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Appendix H
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PDSA CYCLE 1
PLAN:
All Certified Community Health Workers (CCHWs) will be trained in use of The Institute of Health and Recovery 5P’s tool and brief
intervention. The Healthy Mommy Healthy Baby CCHWs will then use the tool with all clients at new intake appointments.
How will you know that the change is an improvement?
If the 5P’s tool is used in >90% of intake appointments with pregnant women.
If the CCHWs find the tool easy to use, and intend to continue its use.
What do you predict will happen?
I predict the 5P’s tool will result in a change in revelation of risk for substance use.
I predict the 5P’s tool will result in a change in the use of written information about smoking cessation, alcohol abstinence, and need to
not use illicit drugs – during pregnancy.
I predict the CCHWs will find the 5P’s tool easy to use and that it does not take any more time than the current system.
PLAN
Person
responsible
(who)
Lisa

When
Feb 2014

2. Complete continuing education credit
application
3. Approve ce application

Mary Ann Swank

Feb 2014

Caroline Michel

Mar 2014

4. IRB application

Lisa

Feb 2014

5. Schedule training session

Carlissa

Feb 2014

6. Conduct training session

Lisa

Apr 2014

7. Conduct survey pre/post education
8. Collect data from intake records

Lisa
Lisa

CCPH
CCPH

9. Second Cycle: Review initial data
and make changes if needed
10. Collect data from intake records

Lisa

Apr 2014
Apr 2014 X 2
weeks
Apr 2014
Apr 2014 X 3
months
Jun 2014

CCPH

List the tasks necessary to complete
this test (what)
1. Outline for continuing education credit

Lisa

Where
Dayton
Children’s
Dayton
Children’s
Dayton
Children’s
WSU
Clark County
Public Health
CCPH

CCPH

11. 2 month post test
Lisa
CCPH
Plan for collection of data:
Chart review at the Public Health Dept. of all new intake patients. CCHWs will keep list of new intake clients, charts are in file folders.
File folders will be made available for review in the Public Health Dept. Review will be hand collected, data de-identified by date of
intake and age of client. Records will be assigned a number and names will not be recorded.
DO: Test the Changes
Was the cycle carried out as planned? Y / N
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Record data and observations:
What did you observe that was not part of our plan?
There were fewer new clients than expected.
STUDY:
Did the results match your predictions? Y / N
Compare the result of your test to your previous performance:
There was a follow up client in the first prenatal group who had risk of substance use identified that was not
identified on previous screening with free form questioning.
What did you learn?
The CCHWs felt the 5P’s screening tool was easier to use with clients who they had a previous relationship.

ACT: Decide to Adopt, Adapt, or Abandon
Adapt:
Y/N
Improve the change and continue testing the plan:
Plans/changes for next test.
Adopt:
Y/N
Select changes to implement on a larger scale and develop an implementation plan and plan for sustainability
Will continue to use the 5P’s tool in the first prenatal program. The 5P’s program will be used in the second
prenatal program (Healthy Families America)

Abandon:
Y/N
Discard the change and try a different one.
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PDSA CYCLE 2
PLAN:
The Healthy Mommy Healthy Baby CCHWs will continue to use the tool with all clients at new intake appointments. The
Healthy Families America staff will use the 5P’s tool with all clients at new intake appointments.
How will you know that the change is an improvement?
If the 5P’s tool is used in >90% of intake appointments with pregnant women.
If the CCHWs find the tool easy to use, and intend to continue its use.
What do you predict will happen?
I predict the 5P’s tool will result in a change in revelation of risk for substance use.
I predict the 5P’s tool will result in a change in the use of written information about smoking cessation, alcohol abstinence,
and need to not use illicit drugs – during pregnancy.
I predict the CCHWs will find the 5P’s tool easy to use and that it does not take any more time than the current system.
PLAN
List the tasks necessary to complete
this test (what)
1. Discuss start of use with Health
Families America Director to begin use
of 5P’s tool with intake appointments
2. Collect data from intake records

Person
responsible
(who)
Lisa
Lisa

When
Apr 2014

Where
CCPH

Apr 2014 X 3
months
Jun 2014

CCPH

3. 2 month post survey of staff
Lisa
CCPH
Plan for collection of data:
Chart review at the Public Health Dept. of all new intake patients. CCHWs and home visitors will keep list of new intake
clients, charts are in file folders. File folders will be made available for review in the Public Health Dept. Review will be
hand collected, data de-identified by date of intake and age of client. Records will be assigned a number and names will
not be recorded.
DO: Test the Changes
Was the cycle carried out as planned? Y / N
Record data and observations:
What did you observe that was not part of our plan?
There were fewer new clients than expected. One CCHW used the 5P’s tool as a follow up for previous
clients, as this was more comfortable. The Healthy Families America (second group) used the 5P’s tool within
30 days of the baby’s birth and were using it as a post partum tool.
STUDY:
Did the results match your predictions? Y / N
Compare the result of your test to your previous performance:
There were eight follow up clients in the first prenatal group who had risk of substance use identified that was
not identified on previous screening with free form questioning.
What did you learn?
The CCHWs felt the 5P’s screening tool was easier to use with clients who they had a previous relationship.
The 5P’s substance use screening tool revealed more risk for substance use that resulted in more brief
interventions with clients.
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ACT: Decide to Adopt, Adapt, or Abandon
Adapt:
Y/N
Improve the change and continue testing the plan:
Plans/changes for next test.
Adopt:
Y/N
Select changes to implement on a larger scale and develop an implementation plan and plan for
sustainability.
The first and second prenatal programs (Healthy Mommy Healthy Baby and Healthy Families America)
will continue to use the 5P’s substance use screening tool as a prenatal tool at initial intake
appointments. New staff will be oriented using the power point and role playing exercise to sustain the
use of the 5P’s substance use screening tool.
Abandon:
Y/N
Discard the change and try a different one.
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Adapted from http://www.ihi.org/resources/Pages/Tools/PlanDoStudyActWorksheet.aspx
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Appendix J
Data Collection Tool (Retrospective and Prospective)
Client
number

Date
of
intake

Race

G

P

Years of
school

Age

Weeks
of preg.

Screening
tool used
(standardized 5P’s)

Risk
identified
(Y/N)

Illicit
drug use
disclosed
(Y/N)

Referral to
Treatment
(Y/N/NA)

Documentation of
intervention/
discussion
(Y/N)

Documentation of
written information
given
(Y/N)
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1

Y/N

Y/N

Y/N

Y / N/NA

Y/N

Y/N

2

Y/N

Y/N

Y/N

Y / N/NA

Y/N

Y/N

3

Y/N

Y/N

Y/N

Y / N/NA

Y/N

Y/N

4

Y/N

Y/N

Y/N

Y / N/NA

Y/N

Y/N

5

Y/N

Y/N

Y/N

Y / N/NA

Y/N

Y/N

6

Y/N

Y/N

Y/N

Y / N/NA

Y/N

Y/N

7

Y/N

Y/N

Y/N

Y / N/NA

Y/N

Y/N

8

Y/N

Y/N

Y/N

Y / N/NA

Y/N

Y/N

9

Y/N

Y/N

Y/N

Y / N/NA

Y/N

Y/N

10

Y/N

Y/N

Y/N

Y / N/NA

Y/N

Y/N

11

Y/N

Y/N

Y/N

Y / N/NA

Y/N

Y/N

12

Y/N

Y/N

Y/N

Y / N/NA

Y/N

Y/N

13

Y/N

Y/N

Y/N

Y / N/NA

Y/N

Y/N

14

Y/N

Y/N

Y/N

Y / N/NA

Y/N

Y/N

15

Y/N

Y/N

Y/N

Y / N/NA

Y/N

Y/N
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Appendix K
IRB Protocol
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Appendix M
Budget Projection
Budget Projection
Budget Item
Initial Training (in monthly
staff meeting)
Initial training
Contact hour for staff
education
Use of tools
- 5P’s substance use
screening tool
- EBPI model
Pamphlets
- March of Dimes
-

Centers for Disease
Control (CDC)
Paper (provided by Clark
County Public Health)
Ink (provided by Clark
County Public Health)
Data Collection (by DNP
student)
Data Analysis (by
biostatistician at Dayton
Children’s)
Total projected cost for
implementation

Cost
Avg CCHW salary $12/hr
$240
X 20 staff
DNP student (no cost)
Free – Pro Bono by Dayton $0
Children’s Hospital
No charge
$0

Total

$0
-

Donated by the
March of Dimes
- No charge from
CDC
$3 X 250 sheets X 1

$3

$20 X 1 cartridge

$20

Avg CNP salary in Ohio
$44 X 4 hr/wk X 12 weeks
Pro bono

$2,100
$0

$2,363
- $263 paid by Public
Health
- $2,100 no cost r/t
DNP student
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